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EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF 
RESPIRATORY PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL 
CORD INJURY 
 
There are over 17,000 new spinal cord injuries (SCIs) every year in the Unites 
States alone. Almost 60% of these injuries occur at the cervical level, potentially leading 
to loss of function in a variety of sensory and motor systems including upper and lower 
limbs, respiratory, and autonomics. In addition to the physical and emotional costs, 
individuals who experience these higher level injuries also face a massive financial 
burden, incurring over $1 million in expenses during the first year after injury in addition 
to substantial yearly costs for the rest of their lifetime. A myriad of therapeutic 
approaches targeting plasticity of spinal circuits have shown efficacy for improving 
functional recovery in preclinical animal models. However, translation of these strategies 
has proved less successful, leaving the SCI population with few effective therapeutic 
options to improve functional outcomes and alleviate the financial toll of their injury. We 
hypothesized that factors that are present in the human population, but difficult to model 
in preclinical studies, such as genetic diversity and sex differences, could determine how 
individuals respond to treatment strategies. Therefore, we investigated how sex and the 
human alleles of the APOE gene (2, 3, and 4), which encode unique isoforms of the 
lipid carrier apolipoprotein E (apoE), modulate a well-described form of spinally 
mediated respiratory motor plasticity that is sufficient to restore breathing function after 
cervical SCI. 
 To test whether E4, the isoform of apoE associated with deficits in synaptic 
plasticity in the brain, also impairs spinally mediated plasticity, we exposed rats to 
episodic serotonin (5-HT) dosing after they had been treated intrathecally with human 
apoE3 or E4. IH induces long term facilitation (LTF) of respiratory motor function, 
which is characterized as a prolonged augmentation of breathing in spinally intact rats. 
LTF also rescues breathing function in the paralyzed hemidiaphragm following unilateral 
cervical SCI. Although rats treated with E3 and E4 did not show significant differences in 
their respiratory response to episodic 5-HT as assessed through diaphragmatic EMG 
recordings, animals treated with E4 did demonstrate a downregulation of synaptic 
NMDA receptors. Interestingly, this effect was only present in animals that had received 
a cervical SCI. Due to the necessity of NMDA receptor signaling in synaptic 
strengthening and the induction of LTF, this indicates that human apoE4 may prevent 
therapeutic strategies from inducing spinal plasticity to mediate functional recovery after 
SCI. 
 To increase the clinical relevance of these studies and investigate how sex 
interacts with APOE genotype to modulate respiratory motor plasticity, we also evaluated 
LTF in male and female targeted replacement APOE mice that express the human alleles 
under the murine promotor. LTF was induced through exposure to therapeutic 
intermittent hypoxia (IH), which is currently in clinical trials for various functional 
outcomes in SCI subjects. There were significant effects of both genotype and sex on the 
respiratory response to IH. Although 4 was inhibitory to plasticity in males, it was 3 
that proved detrimental in females in the absence of injury. In contrast, injured males 
showed no significant difference between genotypes while injured 4 females 
experienced a decline in breathing activity compared to those expressing 3.  
Together, these results support the hypothesis that sex and genetic background 
may determine individuals’ propensity towards or against plasticity and functional 
recovery after SCI. By contributing to our understanding of translational barriers for SCI 
therapeutics, this investigation will inform the development of personalized medicine to 
overcome these obstacles. 
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CHAPTER 1. INTRODUCTION 
1.1 Spinal cord injury 
Spinal cord injuries (SCI) are life-threatening events that cause permanent 
disruptions of central nervous system (CNS) physiology, leading to impaired mobility 
and loss of independence, which dramatically impacts injured individuals’ quality of life. 
Depending on the severity and level of injury, these events can damage both motor and 
sensory function, as well as autonomic control throughout the body from the neck down. 
Worldwide there are estimated to be up to 500,000 new SCI cases each year and close to 
300,000 people are currently living with an SCI in the United States alone.1,2 The 
majority of individuals who sustain SCIs are males and either above the age of 60 or 
under the age of 30.1 In America’s aging population, an increasing number of injuries, 
close to 32%, are due to falls, although most result from vehicular accidents.2 In addition 
to the physical toll of the injury, SCI is a source of significant financial burden, costing 
over $1 million in the first year after a high cervical injury.2 Injured persons whose 
economic status is below the poverty line have a 62% higher mortality rate than those 
considered to be above the poverty line.2,3 Despite decades of research dedicated to SCI 
research, life expectancy after injury has not increased since the 1980’s and there are 
currently no treatments clinically approved that effectively restore function.2,4 While 
numerous experimental strategies have been effective in improving outcomes after SCI in 
a preclinical animal models, and many have entered clinical trials, few have shown 
sufficient efficacy in the human SCI population to be successfully translated for 
widespread clinical use. This indicates that there may be heretofore overlooked or 




injury and how this recovery, whether spontaneous or in response to therapeutics, varies 
from person to person. Elucidating the role that genetic background and sex differences 
play in determining the propensity for recovery or the efficacy of treatment strategies in 
unique individuals may aid us understanding and overcoming translational barriers for 
SCI therapeutics. 
 
1.1.1 SCI Pathology 
SCI is a complex and heterogeneous injury. Over a century ago, it was proposed 
that spinal cord injury pathophysiology could be divided into primary and secondary 
insults.5 The primary injury consists of the initial event that damages the tissue of the 
spinal cord and disrupts the neural circuitry housed within. The spinal cord is a crucial 
bidirectional relay between the brain and the periphery, transmitting signals that supply 
the brain with sensory information, as well as carrying inputs for the control of motor and 
autonomic functions. In addition to functioning as a relay, the control of many crucial 
physiological functions and reflexes also originates in the cord, which contains circuits 
and central pattern generators that are distinct from those located supraspinally6–9. Any 
mechanical force that damages these pathways can lead to motor and sensory deficits. 
However, this initial trauma is not the only concern for people who sustain an SCI. 
Following the primary injury, a cascade of events wreak havoc on the damaged spinal 
cord tissue. Hypoxia due to a loss of blood flow, excitotoxicity from excessive glutamate 
release, activation and infiltration of inflammatory cells, mitochondrial dysfunction, and 




The depletion of both neuronal and non-neuronal cells, along with axonal 
demyelination and Wallerian degeneration lead to cavitation of the spinal cord at the 
lesion epicenter.14–17 Axonal and myelin debris, cytokines, and oxidative stress trigger the 
activation of glial cells hours after injury.18,19 In an attempt to aid in wound repair, 
astroglial processes hypertrophy and overlap, forming a barrier around the lesion cavity.20 
Astrocytes also upregulate production of chondroitin sulfate proteoglycans (CSPGs) and 
other components of the extracellular matrix that contribute to formation of the glial scar. 
Injury also stimulates peripheral monocyte-derived macrophage infiltration of the spinal 
cord. These cells accumulate with CNS-resident macrophages in the lesion cavity.21 
Macrophages then recruit perivascular fibroblasts to accumulate in the lesion site.22 By 7 
days post injury, the lesion core is filled with a fibronectin matrix secreted by these 
fibroblasts, forming a fibrotic scar in the lesion core that is encompassed by the glial 
scar.23,24 
In addition to the astrocytes and fibroblasts that accumulate at the lesion site after 
injury, immune cells from both the CNS and the periphery also contribute to secondary 
the injury, scarring, and tissue repair. Microglia are the resident immune cells of the 
central nervous system. In the uninjured CNS, microglia dynamically function as 
sentinels, extend and withdrawing their processes in a matter of minutes to monitor their 
surroundings. These processes are capable of engulfing components of the surrounding 
tissue and transporting them back to the soma.25 Microglial processes monitor synaptic 
functioning by directly contacting synapses in response to neuronal activity, which aids 
in their crucial role of synaptic pruning during development and after injury.26,27 Upon 




classically considered pro-inflammatory or anti-inflammatory, respectively, in 
resemblance to macrophage classification. M1 macrophages and microglia secrete 
reactive oxygen species and cytokines such as IL-12, IL-1, and IFN which contribute 
to tissue damage after injury.28,29 Conversely, the cytokine expression profile of cells with 
an M2 phenotype primarily consists of anti-inflammatory molecules including IL-10, IL-
13, and IL-7, which encourage neuron growth.28,29  
In recent years, the accuracy of classifying macrophages and microglia in a strict 
M1 or M2 dichotomy has been called into question. After CNS injury, macrophages and 
microglia in the lesion penumbra simultaneously express both M1 and M2 markers and 
the expression of these molecules changes over time, indicating that their response to 
injury is too complex and dynamic to be characterized dichotomously as either pro- or 
anti- inflammatory.30 One such example of how these terms can be misleading is in 
reference to the cytokine TNF-. Historically, TNF- has been considered pro-
inflammatory. Evidence shows that TNF- damages mitochondria, leading to reactive 
oxygen species production, and ultimately causing apoptotic or necrotic cell death.31,32 
However, TNF- also plays an important role in synaptic plasticity. TNF- signaling 
stimulates an upregulation of synaptic AMPA receptors and strengthens excitatory 
synapses, demonstrating that it has divergent functions in cytotoxicity and protection of 
synaptic integrity.33,34 Indeed, the inflammatory milieu initiated by SCI may be a driver 
of secondary tissue damage, while also presenting a potent and dynamic process that 





1.1.2 Assessment of Injury Severity 
Both primary and secondary injury contribute to the overall severity of an 
individual’s SCI. Within the first 72 hours after injury, clinicians assess the extent of the 
neurological injury using the American Spinal Injury Association Impairment Scale 
(AIS). The AIS identifies the neurological level of injury (NLI) and evaluates both 
sensory and motor function below this level. The NLI is identified as “the most caudal 
segment of the spinal cord with intact sensation and antigravity muscle function”.35 The 
injury is then designated as “complete” if there is no sparing of sensory or motor function 
at the sacral spinal cord. Complete injuries receive an AIS grade of A. Otherwise, the 
injury is deemed incomplete and given a grade of B-E, depending on the amount of motor 
and sensory function preserved caudal to the NLI. An AIS grade E represents normal 
sensation and motor function.35 In people who experience a complete injury, a zone of 
partial preservation may be observed. This refers to dermatomes and myotomes caudal to 
the NLI that retain partial innervation.36  
Over time after the initial injury, individuals’ AIS grade can be re-evaluated to 
measure spontaneous rate of recovery  and is used as a outcome measure in clinical trials 
for SCI treatment strategies.37–39 The majority of people with injuries of AIS grade B and 
C improve by one AIS grade by 6 months post injury without any intervention. However, 
only a third of people with AIS A injuries changed classification by 6 months and only 
10% of AIS D patients show improvement in AIS grade during this time.39 Some 
concerns over the utility of the AIS have been raised due to its emphasis on sparing of 
sensorimotor function at the sacral levels, which could distract from the overall 




outcome measure.39 In fact, the design of the AIS allows it to reflect an increase in grade 
despite functional deterioration and vice versa.40 
Additional assessment of injury severity include quantitative sensory testing, in 
which vibratory and thermal stimuli are applied to dermatomes caudal to the NLI in order 
to evaluate the function of the dorsal columns and spinothalamic tract, respectively. This 
testing provides a more quantitative analysis of sensation than the AIS sensory score.41 
Conduction in the spinal cord can also be measured by electromyography (EMG) or 
motor-evoked potentials, approaches that are advantageous due to their efficacy in 
unconscious patients. These evaluations of descending motor tracts are predictive of 
functional outcome, allowing clinicians to tailor treatment plans for individuals in order 
to maximize their functional improvement.42,43 In addition to sensorimotor assessments, it 
is also crucial to monitor impairments of the autonomic nervous system. Exposure to 
stimuli that cause vasoconstriction leads to an increase in blood flow to the skin that can 
be measured above and below the NLI. Since vasoconstriction is controlled by the 
sympathetic nervous system, vasomotor reflex responses can provide an indication 
autonomic damage after SCI.44 
An emerging strategy for assessing severity and predicting outcomes after SCI is 
the discovery and classification of biomarkers. Biomarkers can be sampled in a variety of 
ways, with recent studies evaluating imaging techniques or collection of serum or 
cerebrospinal fluid (CSF). T2-weighted MRI provides visualization of grey versus white 
matter, allowing for the detection of compression, which is predictive of motor and 
sensory deficits in non-traumatic SCI.45 Data published by Brian Kwon and colleagues 




as certain subsets of microRNAs in CSF to indicate current AIS grade and provide a 
prognosis for AIS improvements over time.46,47 Similarly, GFAP and neurofilament 
protein concentrations in serum also have diagnostic value in predicting SCI severity and 
outcomes.48,49 Analysis of these biomarkers associated with specific AIS grades or injury 
severities has potential to aid the assessment of patients who cannot be graded on the AIS 
due to unconsciousness, damage to other body systems, or other issues of noncompliance. 
Accurate biomarkers could therefore contribute to accurate characterization of injuries for 
enrollment in SCI clinical trials and provide additional outcome measures for therapeutic 
efficacy.50 
 
1.1.3 Supportive Care After Injury 
 There are currently no FDA-approved drugs that are recommended as standard of 
care for the treatment of spinal cord injury. However, first responders and clinicians can 
take action to minimize damage to the spinal cord tissue and prevent disturbances in other 
body systems. One of the first decisions that must be made is whether to perform surgical 
decompression to relieve pressure on the spinal cord and if so, when. In cases of central 
cord syndrome or other stable or non-traumatic spinal cord injuries, spinal decompression 
may not always be necessary due to the high likelihood of spontaneous improvement.51 
However, in many cases of traumatic SCI, surgical decompression is recommended 
within the first 24 hours after injury due to its correlation with greater improvements in 
neurological outcome or AIS grade.52 Non-surgical decompression using spine traction, 
in which weight is applied to the skull in order to pull it away from the shoulders and 




 In the first day after injury, SCI patients are at risk for hemodynamic instability 
due to autonomic dysreflexia or loss of sympathetic tone during neurogenic shock. 
Compression of the spinal cord can also prevent blood flow to the lesion penumbra, 
creating a hypoxic state. In order to prevent hypoperfusion, hypotension, and 
bradycardia, guidelines in the last decade have recommended that mean arterial pressure 
(MAP) is maintained at 85-90 mmHg during the first week post injury.54 This aggressive 
maintenance of MAP is associated with enhanced neurological outcomes measured by 
AIS grade conversion, walking ability, and bladder function.55,56 Unfortunately, 
administration of vasopressors comes with risks that must also be considered. Use of 
common vasopressors cause complications including tachycardia, bradycardia, atrial 
fibrillation, and even elevations in troponin, a biomarker of heart damage.57 Recent 
research in humans and animal models has explored when and to what extent MAP 
should be elevated after injury.58–60 Even chronically after injury, the spinal cord tissue 
caudal to the injury can remain in a state of hypoxia, limiting the potential for functional 
recovery.12 
 A major concern for individuals with impaired mobility and sensation after SCI is 
the development of pressure ulcers. The second most prevalent cause of death after SCI is 
septicemia, often as a result of epidermal ulceration.61 Pressure ulcers develop in 
response to prolonged pressure on the skin, especially over bony areas, which results in a 
period of ischemia. Numerous studies have examined the impact of body positioning 
while patients are in supine or prone recumbency on the development of pressure 
ulcers.62,63 While body positioning techniques can be used to reduce pressure on the skin 




schedule for regularly turning patients in bed.64,65 This redistributes pressure and restores 
blood flow to areas that are at risk for developing ulcers. Similarly, once quadriplegics or 
paraplegics are maintaining a sitting position for extended periods after injury, pressure 
relief maneuvers, such as leaning forward, reclining, and doing push-ups must be 
performed regularly to reduce the risk of developing ulcers.66–68 However, multiple 
factors, including individual skin physiology, age, weight, and response to stress must be 
taken into consideration, emphasizing the need for personalized care in the SCI field. 
For people who sustain an injury at or above the T6 spinal level, preventing 
episodes of autonomic dysreflexia (AD) becomes a constant concern beginning a few 
months after injury. Below the level of injury there is a disruption in the regulation of 
preganglionic sympathetic neurons, which reside in the intermediolateral nucleus of the 
spinal cord between the first thoracic and second lumbar level.69 The sympathetic 
division of the autonomic nervous system is crucial in the control of hemodynamics.70 
After injury, sympathetic tone below the level of injury becomes independent of 
supraspinal control, while above the lesion it is still governed by brainstem inputs. 
Unperceived noxious stimuli including hyperextension of the bowel or bladder, ill-fitting 
clothes or shoes, pressure ulcers, or skin lacerations caudal to the injury activate the 
sympathetic nervous system.71 The sympathetic “fight or flight” response instigates 
vasoconstriction to increase arterial blood pressure, which is sensed by baroreceptors of 
the carotid sinus.71,72 Baroreceptor feedback to the medullary nucleus solitarius initiates a 
conversion from sympathetic to parasympathetic dominance to slow the heart rate and 
decrease blood pressure. However, sympathetic neurons below the NLI that lack 




to systolic arterial pressures as high as 325mmHg.73,74 If left untreated, AD puts patients 
at risk for stroke, cardiac arrest, seizures, and death.75 
Maladaptive plasticity in the spinal cord after injury may cause hypersensitivity 
and enhanced nociception, increasing the likelihood of a stimulus being perceived as 
noxious.76,77 Since the stimuli initiating AD are unperceived by the patient due to deficits 
in sensory function, episodes of AD can happen multiple times a day. They are 
characterized by sweating, headache, stuffy nose, and flushing above the level of injury.71 
Once AD has been triggered, the most effective way to terminate it is by identifying and 
removing the stimulus. However, AD is also be treated pharmacologically with 
nitroglycerine paste or an L-type calcium channel blocker, which relax smooth muscle to 
alleviate vasoconstriction.78,79 
 
1.1.4 Clinical trials for SCI interventions 
Although there are currently no FDA-approved drugs for the treatment of SCI, a 
search on clinicaltrials.gov produces over 800 clinical trials for spinal cord injury, 
including 427 that have already reached completion. Many of these trials aim to alleviate 
a variety of comorbidities associated with SCI including neuropathic pain, cardiovascular 
disease, sleep apnea, and loss of muscle mass. Other trials are focused on the translation 
of drugs or other therapeutic approaches that have shown potential for improving motor 
and sensory function to enhance independence and quality of life. Representative 
examples of currently ongoing clinical trials for SCI that target a variety of complications 
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In addition to these experimental treatments, many clinical trials have also tested 
the efficacy of neuroprotective drugs that could reduce secondary injury. Minocycline, an 
antibiotic which reduces apoptosis of oligodendrocytes and microglia, was proved safe 
and feasible in a Phase II trial80 and is now being investigated in an ongoing Phase III 
trial (NCT01828203). Inhibition of endogenous opioids after injury has also shown 
neuroprotective effects, leading to the development of clinical trials for opioid blockers 
such as naloxone and thyrotropin-releasing hormone.81,82 These antagonists have shown 
preclinical efficacy in dampening excitotoxicity, preventing ischemic damage, and 
improving functional recovery after SCI, although results from clinical trials were less 
conclusive.81–83 
Importantly, the only drug ever approved for acute SCI was also a neuroprotective 
agent. Methylprednisolone sodium succinate (MP) is a glucocorticoid with antioxidant 
capabilities that showed efficacy in preventing lipid peroxidation and neurofilament 
degradation, while also improving blood flow to the injured cord. 84,85 In a series of three 
clinical trials known collectively as the National Acute Spinal Cord Injury Studies 
(NASCIS I, NASCIS II, NASCIS III), various dosages of MP were tested at different 
time points after injury for a duration ranging from 1 day up to 10 days. Results from 
these studies demonstrated that high dose MP administered within 8 hours of injury 
resulted in improved sensory and motor recovery at 6 weeks and 6 months.82,86,87 
However, subsequent criticism of the studies’ analyses and concerns over gastrointestinal 
side effects and increased infection risk led to removal of MP from standards treatment of 





1.1.5 Experimental approaches for preserving and restoring function after SCI 
A plethora of diverse experimental therapeutic approaches have been evaluated for 
their potential to preserve or improve function after SCI in preclinical animal models and 
in clinical trials. For simplicity, these techniques can be divided into the categories of: 
neuroprotection, those enhancing plasticity, and those promoting regeneration. In 
addition to these unimodal methods, combinatorial approaches have also been developed 
that target both the preservation of existing tissue and the cultivation of new axon growth 
and synaptic connectivity.  
As described in section 1.1.2, initial damage caused by an SCI leads to subsequent 
secondary injury events including scarring, inflammation, oxidative stress, mitochondrial 
dysfunction, and axon demyelination and degeneration. Neuroprotective strategies are 
those that aim to mitigate or prevent secondary injury cascades in order to preserve tissue 
and functional neural circuitry in the spinal cord. Some neuroprotective compounds have 
already entered into clinical trials, including MT-3921 and Riluzole, seen in Table 1. 
Indeed, the only drug that has been approved by the FDA for the treatment of SCI was 
the neuroprotective corticosteroid methylprednisolone.82,87 These trials also investigated 
other neuroprotective agents naloxone and tirilazad, both of which were less effective in 
restoring function. While later clinical guidelines advised against the use of MP, these 
guidelines remain a subject of contention for clinicians.90 Regardless, MP’s ability to 
improve functional recovery emphasizes that neuroprotective agents are powerful tools in 




It was once thought that damaged axons in the CNS were incapable of regeneration 
due to inhibitory properties of the CNS environment.91,92 Indeed, in 1981, David and 
Aquayo proved that injured spinal cord axons are capable of elongating over long 
distances when the CNS environment is replaced by a peripheral nerve graft.93 This 
seminal discovery led to decades of research dedicated to finding treatment strategies that 
create a CNS microenvironment that is more conducive to axon growth. In addition to 
peripheral nerve grafts, growth permissive environments have been inserted into the 
spinal cord in the form lab-manufactured scaffolds of various materials.94 Therapeutic 
approaches also include amplifying the presence of neurotrophic factors such as BDNF 
(brain-derived neurotrophic factor), NT-3 (neurotrophin-3), or GDNF (glial cell-derived 
neurotrophic factor) to activate genes associated with regeneration.95,96  
Instead of increasing growth-promoting molecules in the CNS microenvironment, 
other strategies remove molecules that are inhibitory to outgrowth. A promising 
therapeutic target is the degradation of chondroitin sulfate proteoglycans (CSPGs), which 
are found in the perineuronal net surrounding CNS neurons. CSPGs are upregulated 
following SCI, creating a barrier around the lesion site that halts axon elongation and 
entraps regenerating end bulbs.97,98 Degradation of CSPGs using the bacterial enzyme 
chondroitinase-ABC (ChABC) removes this inhibitory boundary and permits axon 
outgrowth and regeneration through the injury site, leading to new functional synaptic 
connections.99 Further studies have also shown the efficacy of interfering with 




Ablation of reactive astrocytes, mediators of glial scar formation after SCI, can 
also create a growth-permissive state at the cost of exacerbating the inflammatory 
response to injury.102,103 However, some of these immune responses to injury can actually 
stimulate axon growth. For example, macrophage-mediated release of oncomodulin 
promotes optic nerve regeneration.104,105 Despite some beneficial effects acutely, 
sustained immune activation leads to neuronal and glial cell death, making it difficult to 
modulate inflammation to stimulate favorable responses while avoiding detrimental 
outcomes.106 In the 1980’s, Schwab and colleagues realized that the myelin produced by 
oligodendrocytes in CNS white matter also acts as a nonpermissive growth substrate and 
neutralization of myelin membrane proteins promotes corticospinal tract regeneration 
through an SCI.107–109 Since these discoveries, approaches that knockout or otherwise 
inhibit receptor binding of the myelin proteins Nogo, MAG (myelin associated 
glycoprotein), and OMgp ( oligodendrocyte myelin glycoprotein) have shown efficacy in 
stimulating both regeneration of injured axons and sprouting of spared fibers.110–113 
Altogether, studies manipulating the injury milieu have provided valuable evidence for 
the competency of CNS axons to regenerate when neuron-extrinsic barriers to growth are 
removed.  
In contrast to approaches that aim to remove inhibitory factors from the 
microenvironment to promote axon elongation, others modulate neural intrinsic factors to 
stimulate the neuronal growth machinery. In a pivotal 2008 study, Park et al. found that 
deletion of cell growth control genes significantly impacted cell survival and axon 
regeneration. Specifically, deletion of the tumor suppressor gene PTEN (phosphatase and 




has also been reproduced in the injured spinal cord, even when PTEN is only transiently 
inhibited by an antagonist peptide or when downstream targets of PTEN are directly 
activated.115–117 Axon regeneration is an energy-intensive process, requiring 
transportation of mitochondria to the growth cone.118,119 Inhibition of PTEN activates 
genes associated with mitochondrial transport and enhanced regenerative capacity, 
indicating that mitochondrial motility may be a key intrinsic factor that influences axon 
regeneration.119,120 In a similar manner to PTEN, expression of a GTPase known as RhoA 
is also implicated in preventing axon elongation.121 RhoA expression is upregulated after 
SCI, leading to downstream increases in inflammation and growth cone to collapse, 
effectively preventing neurite outgrowth.122 The FDA-approved non-steroidal anti-
inflammatory drug ibuprofen suppresses Rho signaling and promotes axonal sprouting.123 
Another fascinating, yet paradoxical way to stimulate the growth machinery of spinal 
axons is through a peripheral conditioning lesion.124 Lesioning the peripheral branch of 
dorsal root ganglion neurons activates signaling pathways that promotes regeneration of 
dorsal column axons after SCI.125 
Although regeneration and sprouting of CNS axons may be considered a form of 
structural plasticity, henceforth plasticity will refer to alterations in the number or 
strength of synaptic connections. While CNS plasticity will be discussed in greater detail 
in section 1.2.3, some therapeutic approaches that target spinal plasticity in the context of 
SCI will be addressed here. Following SCI, spinal plasticity can either be beneficial, 
leading to functional improvement, or maladaptive, often exacerbating spasticity, pain, 
and autonomic dysreflexia. One way to combat maladaptive plasticity is through training 




firing.126,127 During such training and exercise protocols, afferent inputs in the spinal cord 
modulate synaptic plasticity through BDNF-dependent mechanisms to improve motor 
function after SCI.128–130  
Neural excitability in the spinal cord can also be modulated through epidural 
stimulation, which has shown efficacy in improving both locomotor and autonomic 
function following SCI.131–135 In epidural stimulation protocols, electrodes are placed 
epidurally over the targeted spinal segments while a pulse generator is implanted in the 
abdominal wall.133,136 A less invasive strategy that enhances plasticity of spinal circuits is 
intermittent hypoxia (IH). IH consists of exposing subjects to bouts of low inhaled 
oxygen (hypoxia) interspersed with periods of normoxia or hyperoxia, which activates 
serotonergic (5-HT) neurons in the raphe.137 These 5-HT fibers extend throughout the 
spinal cord, allowing them to modulate the function of various motor systems.138 Clinical 
studies have demonstrated improvements in breathing, locomotion, and upper limb 
function after exposing spinal cord injured subjects to IH.139–143 The functional 
improvements that result from IH and epidural stimulation can be further augmented by 
combining them with task-specific training.136,144 All of these therapeutic strategies are 
currently under investigation in clinical trials (Table 1.) 
Some therapeutic approaches and combinatorial treatment strategies target 
multiple mechanisms of neuroprotection, regeneration, or plasticity. In preclinical and 
clinical investigations, transplantation of a variety of cell types has been of interest due to 
the cells’ ability to create a protective and pro-regenerative microenvironment.145 




or mesenchymal stem cells have proven effective preclinically in decreasing lesion cavity 
size and enhancing the amount of spared tissue after injury.146–149 They can also prevent 
the spread of inflammation throughout the spinal cord.150 Neural progenitor cell grafts are 
capable of forming synaptic connections with host axons to create relays through an SCI 
lesion site in monkeys.151 Foundational work from the Bunge lab emphasized the power 
of Schwann cells in reducing lesion cavitation, promoting axon regeneration, and 
remyelinating fibers to restore axon conduction.152 Combining cell grafting techniques 
with additional strategies such as ChABC-induced PNN degradation, scaffolds that fill or 
bridge the lesion, peripheral nerve grafts, or genetic modification to enhance expression 
of pro-regenerative molecules can also aid in promoting functional recovery.153–155 
1.2 Breathing Before and After Trauma 
Breathing is one of the body’s most crucial functions. Injury and disease states 
that impact breathing are by nature life-threatening and require immediate medical 
intervention. If the body’s natural breathing function cannot be sufficiently maintained, 
patients may require permanent aids to ensure proper ventilation and adequate tissue 
oxygenation. Breathing is primarily mediated through rhythmic contractions of the 
diaphragm muscle, which derives its innervation from motor neuron pools in the cervical 
spinal cord. The neural circuitry that sustains life by providing excitatory input to these 
motor neurons can be damaged by high level cervical spinal cord injuries, making the 





1.2.1 Neural Control of Breathing 
Breathing is a complex behavior that, by necessity, must be capable of adapting to 
changes in the internal and external environment. Alterations in oxygen or carbon dioxide 
levels in the blood, physical exertion, altitude, and many other factors stimulate the body 
to adjust breathing to ensure that proper tissue oxygenation is maintained in any setting. 
Multiple respiratory centers in the brainstem exert control over inhalation and exhalation, 
as well as augmented breathing behaviors that are utilized to clear the airways. 
Breathing consists of three phases: inspiration, postinspiration, and expiration. In 
eupneic breathing, or breathing at rest, breathing rhythm is primarily driven by active 
muscle contractions of the inspiratory phase, while expiration is typically passive. The 
rhythmicity is generated by a region of the ventral medulla known as the pre-Bötzinger 
Complex (preBötC).156 The groups of neurons from the ventral medulla that would later 
become known as the preBötC first attracted attention because they maintain discharge 
patterns consistent with inspiratory rhythm both in vivo and in vitro, even when isolated 
from afferent feedback.156,157 Their axons decussate to communicate with contralateral 
breathing centers and ensure bilateral synchronicity.158 Neurons of the preBötC also 
extend to other pontine or medullary nuclei that modulate ventilatory behaviors including 
the nucleus tractus solitarius (NTS), the retrotrapezoid nucleus, the nucleus ambiguous, 
and various regions of the raphe. This densely connected network provides integration of 
afferent information to adjust breathing in response to an organism’s environment.158,159 
Rhythmic firing of excitatory preBötC neurons induces the active inspiratory phase of 
breathing.160 Therefore, hyperpolarization or depolarization of these neurons decreases or 




neurons leads to severe breathing deficits and apnea in both rodents and larger species 
such as goats.162–164  
Axons projecting caudally from the preBötC communicate with the rostral ventral 
respiratory group (rVRG) in the caudal medulla. Transmission of the rhythmic signals to 
the rVRG is crucial as these premotor neurons will ultimately control the pace of 
diaphragmatic contractions. Premotor neurons in the rVRG provide glutamatergic input 
to phrenic motor neurons (PMNs) in the ventral horn of spinal cord levels C3-C6.165–167 
PMNs are crucial for inspiration because it is their axons that will exit the spinal cord to 
form the phrenic nerve. The phrenic nerve innervates the diaphragm and signals it to 
contract inferiorly, increasing the volume of the thorax and creating negative pressure to 
draw air into the lungs. Thus, the pre-BötC drives rhythmic inspiration by governing 
excitatory input to PMNs.160  
PMNs also receive serotonergic innervation from the caudal raphe, which is 
crucial for breathing adaptation in response to carotid body activation.168,169 The carotid 
body, located at the bifurcation of the common carotid artery, contains chemoreceptors 
that are sensitive to oxygen levels. Decreases in the arterial partial pressure of oxygen 
(pO2) activates the carotid body, which is innervated by the glossopharyngeal nerve. 
Afferent information from the carotid body is then processed in the nucleus solitarius and 
the nucleus ambiguous, which communicate with the caudal raphe to modulate 
serotonergic input to the phrenic motor nucleus.137,170,171 Neurons of the raphe also 
possess their own chemoreception capabilities, which is exemplified by their ability to 




both peripheral and central chemoreception provides a mechanism for modulating 
breathing activity in response to environmental changes. 
Following the inspiratory phase, postinpiration serves to prolong the contraction 
of the diaphragm, allowing more time for gas exchange across alveolar surfaces.173 
Laryngeal muscles also contract in order to guard against airway collapse during the 
subsequent expiratory phase.174 Although the expiration is passive during eupnea, 
expiratory muscles can be recruited when oxygen levels are reduced. For example, 
abdominal muscles are recruited during the expiratory phase when rats are exposed to 
hypercapnic or hypoxic conditions.175 Expiration also becomes active in response to 
increased ventilatory demand during exercise and high metabolic rate. In this case, 
pressure generated by abdominal muscles reduce end-volume of the lungs during 
expiration, thereby increasing tidal volume.176 Active expiration is most commonly 
utilized during speech, laughter, or crying because these expressions require a more rapid 
inspiratory phase and a more prolonged expiratory phase.177   
 
1.2.2 Respiratory Deficits after SCI and Approaches for Restoring Breathing Function 
Almost 60% of SCIs occur at the cervical level2. Such high level injuries can 
interrupt the descending pathways that extend from brainstem respiratory nuclei to the 
C3-C6 spinal cord levels where they synapse on PMNs that innervate the diaphragm. 
This leads to severe deficits in breathing, often necessitating the use of an artificial 
ventilator and increasing hospital length of stay and associated financial burdens.178,179 
Ventilator-dependency increases the risk of pneumonia and other respiratory infections, 




decreases the life expectancy of injured individuals.181 Cervical level injury also increases 
the incidence of sleep disordered breathing, primarily in the form of obstructive sleep 
apnea, which is a precursor to cardiovascular disease, insulin resistance, and impaired 
cognitive function.182–184 
During the first year after injury, many injured individuals who required 
ventilation are successfully weaned from ventilator use. However, weaning likelihood 
declines in patients who experience higher level lesions (C1-C3) and in those who 
undergo tracheostomy, leaving many individuals dependent upon ventilators for extended 
periods of time.185 This can lead to ventilator-induced lung injury, as well as diaphragm 
muscle atrophy.186–188 In order to restore diaphragm strength and replace the use of a 
ventilator, some individuals have the option of undergoing implantation of a diaphragm 
pacer. Diaphragm pacing (DP) requires that electrodes be inserted into multiple sites in 
the diaphragm in addition to a subcutaneous ground electrode. A pulse generator then 
electrically stimulates diaphragmatic contractions to maintain breathing while the patient 
is removed from the ventilator.189,190 However, if PMNs in the spinal cord or the phrenic 
nerve itself is injured, this renders DP ineffective.190 A less invasive approach to 
stimulating respiratory drive and enhance breathing function after SCI is through 
therapeutic IH, which will be addressed further in the following section. 
 
1.2.3 Respiratory Motor Plasticity 
In the early twentieth century, it was commonly believed that the central nervous 
system did not change once development was complete. Neuronal cell counts, as well as 




throughout adult life. However, this dogma was challenged, and ultimately rejected, as 
evidence emerged revealing the plastic nature of the CNS. One of the first scientists to 
propose that the CNS changes in response to experience was Donald O. Hebb in 
1949.118,191 As Hebb observed, when a presynaptic cell repeatedly activates a 
postsynaptic cell, it leads to increased strength of their synaptic connection. In the 1970’s, 
this finding led to the discovery of long term potentiation (LTP), in which stimulation of 
perforant pathway caused potentiation of excitatory post-synaptic potentials.192,193 This 
form of plasticity is dependent upon signaling through NMDA receptors, which then 
increases trafficking of AMPA receptors to the post-synaptic membrane, thereby 
strengthening synaptic connections.194,195 
 Since Hebb’s time, LTP has become a well-characterized example of plasticity in 
the brain.196 Similarly, it has long been known that spinal cord circuits are also capable of 
changing in response to external stimuli. Like the brain, the spinal cord is capable of 
instrumental learning, both before and after spinal cord injury.197–199 In addition, this 
learning is dependent upon glutamate receptor signaling, which causes synaptic 
sensitization similar to that produced by hippocampal LTP.200 While this form of 
plasticity produces an advantageous increase in synaptic strength, some modes of 
plasticity in the spinal cord may be maladaptive. For example, following spinal cord 
injury in rodent models, loss of inhibitory GABAergic signaling, increased sprouting of 
afferent fibers, and increased membrane trafficking of glutamate receptors all contribute 
to development of neuropathic pain while impairing spinal learning.201–205 
Spinal cord plasticity is also evident in the neural control of breathing. In 1895, 




from the brainstem to the phrenic motor nucleus exhibited plasticity in response to 
cervical spinal cord hemisection.206 This SCI model severs one side of the cord, 
paralyzing the ipsilateral hemidiaphragm while leaving the contralateral cord intact. 
Following unilateral interruption of descending respiratory pathways, compensatory 
breathing activity is exhibited in the contralateral phrenic nerve207. In addition, breathing 
activity returns to the ipsilateral phrenic nerve as respiratory drive intensifies207,208. These 
studies, along with others6,209,210, demonstrate the potential of spared or latent spinal 
pathways to modulate breathing activity after cervical SCI. The pathway that Porter 
detected in the nineteenth century later became known as the crossed phrenic pathway 
(CPP), which descends from the RVRG and decussates at the level of the phrenic motor 
nucleus to synapse on contralateral PMN, thereby circumnavigating the cervical 
hemisection206,211. Although it remains latent during eupneic breathing, it can be activated 
by physiologically or pharmacologically amplifying respiratory drive after SCI, thereby 
restoring function to the paralyzed hemidiaphagm207,212. Presence of the CPP has been 
validated in a number of species including rats, mice, guinea pigs, dogs, and cats207,213–
215. 
Respiratory motor plasticity also manifests as a prolonged increase in breathing 
motor activity following stimulation of the carotid sinus nerve216,217 or exposure to 
intermittent hypoxia218,219. This well-described spinal plasticity, termed long term 
facilitation (LTF), has been shown to augment diaphragmatic (phrenic nerve), external 
intercostal (intercostal nerves), and upper airway muscle activity (hypoglossal nerve)220–
222. Depending on the IH protocol used, i.e. length and number of hypoxic bouts and 




dependent signaling mechanisms in PMNs223–225. These are termed the Q and S pathway, 
respectively226. These signaling cascades and the crosstalk between them have been well 
described in rats over the past three decades, providing optimized IH protocols and a 
depth of knowledge for how to modulate the pathways pharmacologically227–230. 
However, very few studies have investigated the impact of IH on the respiratory activity 
of mice. No standardized IH protocol for mice is currently used across labs. However, 
hypoglossal and ventilatory LTF have been demonstrated in mouse studies that utilized 
different levels of hypoxia (7-14%) and number of hypoxic bouts (3-12 bouts, each of a 
3-5 minute duration)231–234.  
While exposure to hypoxia stimulates respiratory motor plasticity by increasing 
respiratory drive, complete elimination of this drive through neural apnea can also lead to 
inactivity induced facilitation of breathing function235–237. Ventilating animals sufficiently 
to maintain arterial O2 eliminates respiratory drive. In the absence of respiratory drive, 
the phrenic nerve ceases firing, causing a neural apnea. A single prolonged period or 
short repeated bouts of neural apnea lead to augmented breathing activity when 
respiratory drive returns235,238. This form of plasticity has been termed inactivity-induced 
phrenic motor facilitation (iPMF)238. In contrast to LTF, iPMF is induced through either 
TNF- or retinoic acid-dependent mechanisms, ultimately activating protein kinase C 
signaling cascades236,237,239.  
Intrathecal TNF- dosing is sufficient to induce iPMF, emphasizing the 
importance of the cytokine’s role in plasticity237. TNF- has also been implicated in 
homeostatic synaptic scaling. Synaptic scaling consists of increases or decreases in 




amount of postsynaptic AMPA receptors240. In response to prolonged periods of synaptic 
inactivity, glia release TNF-, which stimulates insertion of AMPA receptors into 
neuronal postsynaptic membranes34,241. Thus, TNF- signaling helps neurons maintain 
the ability to alter their activity in response to their environment242. However, due to the 
effect of TNF- on glutamate receptor localization, it also has potential to make neurons 
more vulnerable to excitotoxic cell death after injury243. Systemic inflammation induced 
by lipopolysaccharide attenuates IH-induced LTF, indicating that inflammatory 
mediators can have both beneficial and detrimental effects on various forms of plasticity, 
perhaps dependent on magnitude and duration of inflammatory response244–246 
 
1.2.4 Long Term Facilitation of Breathing after SCI 
Early studies from Porter and others demonstrated the presence of respiratory 
drive-induced plasticity in breathing circuitry following spinal hemisection.206–208 These 
discoveries prompted investigations into the prospect of alleviating cSCI-induced 
breathing deficits by increasing respiratory drive through exposure to IH. Almost 20 
years ago, Fuller et al. showed that IH conditioning could restore ipsilateral 
hemidiaphragm function following unilateral cervical SCI.139 The injury model used in 
this and many other related studies was a lateral C2 hemisection, in which the left half of 
the spinal cord is transected at the C2 spinal cord level, thereby severing ipsilateral 
bulbospinal respiratory pathways and rendering the ipsilateral hemidiaphragm chronically 
paralyzed.139,218,247 As early as four weeks after injury, therapeutic IH is capable of 
restoring breathing activity for at least sixty minutes after cessation of IH.247 Activation 




present in the region of the phrenic motor nucleus, which may explain why IH is 
ineffective at restoring function acutely after injury when 5-HT fiber sprouting has yet to 
occur.218,247  
 Exposure to IH can also illicit long term facilitation of ventilation in human 
subjects, both in the presence or absence of cervical spinal cord injury.142,248 LTF is 
expressed equally in males and females when subjects are spinally intact.249 However, 
data from Tester et al. suggests that the ventilatory response to IH may differ between 
males and females following SCI, providing evidence of enhanced LTF in males.142 IH is 
currently in clinical trials to test its impact on a variety of outcomes after SCI, including 
upper and lower limb function, alleviation of sleep apnea, and breathing (Table 1.).250–253 
In these studies, it will be essential to consider sex as a biological variable to evaluate the 
true efficacy of IH in the SCI population 
1.3 Genetic influences on neural plasticity 
Spinal plasticity induced by therapeutic approaches such as exercise and training, 
electrical stimulation, and intermittent hypoxia have the potential to promote recovery of 
function after spinal cord injury. However, little is known about how various factors in 
the human population, such as sex and genetic background of injured individuals, could 
impact the expression of spinal or respiratory plasticity. This section will discuss how 
heterogeneity in the human population could modulate the potential for plasticity. 
Although many of these factors have previously been studied in the context of brain 





1.3.1 Brain-derived neurotrophic factor 
BDNF plays a significant role in modulating dendritic protein synthesis, 
neurotransmitter release, and glutamate receptor trafficking, demonstrating its importance 
in regulating synaptic plasticity both pre- and post-synaptically.254–259 A single nucleotide 
polymorphism of the BDNF gene in which valine is substituted with methionine at codon 
66 (Val66Met) has previously been implicated in the inhibition of synaptic plasticity in 
the brain, resulting in memory impairment.259–262 In the context of traumatic brain injury, 
studies in combat veterans demonstrate that BDNF polymorphisms differentially 
modulate the recovery of cognitive function.263,264 However,  their impact on neural 
recovery after SCI remains unexplored. 
Individuals who express the Val66Met polymorphism have a diminished response 
to  transcranial magnetic stimulation (TMS), which alters the excitability of neural 
circuits in the brain to improve motor rehabilitation after stroke.265 TMS has also shown 
efficacy in improving outcomes after SCI, although it is unknown whether this effect is 
similarly altered by the Val66Met polymorphism.266 However, the Val66Met 
polymorphism does prevent the plastic responses of spinal cord circuitry that are typically 
induced by electrical stimulation.267 This SNP could therefore have repercussions for the 
efficacy of these and other therapies that increase plasticity in the spinal cord to restore 
function after SCI.129 For example, spinal plasticity in the form of IH-induced LTF is 
dependent upon synthesis of new BDNF and its binding to the TrkB (tropomyosin 
receptor kinase B) receptor.268 Interestingly, the magnitude of IH-mediated BDNF 





1.3.2 Tropomyosin receptor kinase B 
BDNF signals through its receptor, TrkB, to modulate synaptic strength.258,269,270 
The Trk family of receptor tyrosine kinases dimerize upon binding of their neurotrophin 
ligands, leading to transphosphorylation of the receptor’s cytoplasmic domain.271 
Phosphorylated residues then serve as docking sites for signal transduction molecules.272 
Downstream signaling triggered by activation of TrkB increases glutamate-evoked 
excitatory postsynaptic currents through NMDA receptors.258,269 Presynaptically, receptor 
activation increases glutamate release.273 Mutations in these presynaptic TrkB receptors 
impair LTP induction, indicating that TrkB signaling modulates synaptic plasticity 
through multiple mechanisms pre- and post-synaptically.274 Behavior of TrkB mutant 
mice suggests that loss of TrkB causes deficits in learning, short term memory, and 
coping responses to stressful stimuli.275 
 Numerous variants of TrkB are naturally occurring, including splice variants and 
those containing single nucleotide polymorphisms (SNPs) in the NTRK2 gene encoding 
TrkB. Due to the importance of BDNF/TrkB signaling in modulating synaptic plasticity 
and depressive behavior, a considerable body of work has investigated the impact of 
these variants on development of depressive disorders in human populations.276,277 
Multiple SNPs within the promotor  and intronic regions of NTRK2 are positively 
correlated with depression and suicide attempts in human populations.278–282 In contrast, 
one TrkB SNP (rs1212171) is correlated with decreased depressive symptoms in females 
with HIV (human immunodeficiency virus), a population known to experience a higher 
incidence of depression.283,284 This disparity points to the complex influence of 




Although it has been established that TrkB signaling is crucial for functional 
recovery after spinal cord injury286,287, it is unknown how recovery and response to 
therapeutics is impacted by polymorphisms in the NTRK2 gene. Spinal plasticity is 
dependent upon activation of TrkB, indicating that alterations in TrkB signaling could be 
detrimental to plastic responses in the spinal cord.268 As an example of spinally-mediated 
plasticity, LTF requires BDNF-dependent activation of TrkB receptors.268 It has been 
proposed that TrkB then stimulates phosphorylation-induced trafficking of glutamate 
receptors to the postsynaptic membrane of PMNs, thereby strengthening connections 
with the CPP.288 Therefore, variants of the NTRK2 gene could have either detrimental or 
beneficial impacts on the induction of LTF, depending on how they alter TrKB ligand 
binding and kinase activity.  
 
1.3.3 Neurotrophin receptor p75 
The p75 neurotrophin receptor binds neurotrophins in both their mature and their 
uncleaved pro- forms to execute a wide range of functions. During development and after 
CNS injury, binding of proNGF (nerve growth factor) leads to p75-induced apoptosis.289 
Interaction of p75 and the Nogo receptor inhibits neurite outgrowth in response to 
myelin-associated proteins.290,291 The p75 receptor also has a role in regulating 
hippocampal synaptic plasticity by altering currents through glutamate receptors. Its 
binding of proBDNF enhances NR2B-mediated currents and increases NMDA receptor-
dependent long term depression (LTD).292 Repeated induction of LTD stimulates 
production of additional proBDNF, which reduces synaptic strength, as well as dendritic 




impairments in LTD.294,295 These studies reveal that while mature BDNF strengthens 
synaptic connections, pro-BDNF depresses synaptic transmission through its interactions 
with p75.295 
A polymorphism in the human p75NTR gene in which serine 205 is changed to a 
leucine (S205L) has been associated with decreased incidence of depressive and suicidal 
behavior compared to individuals with ser205.296,297 While this could indicate a protective 
role of this polymorphism in regard to mood disorders, it is unknown whether this 
polymorphism performs a similar role in other neural disorders or neurotrauma. 
However, complete inhibition of proNGF/75 receptor interactions improves limb 
function, coordination, and bladder function after experimental SCI.298,299 The role of p75 
signaling in increasing NR2B-mediated currents is also of not because NR2B-containing 
NMDA receptors are crucial in mediating hyperexcitability in the dorsal horn, and effect 
which is associated with neuropathic pain.300,301 Therefore, the S205L polymorphism 
could alleviate neuropathic pain if it alters mechanisms of maladaptive plasticity that 
increase NR2B signaling in the dorsal horn.  
 
1.3.4 Apolipoprotein E 
Apolipoprotein E (apoE) is a lipid transport protein that is primarily synthesized 
in the liver and the brain.302 In the periphery, apoE is typically a component of very low 
density lipoproteins (VLDL) and mediates cellular uptake of triglycerides and cholesterol 
through high-affinity binding to the low-density lipoprotein receptor family. In the CNS, 
astrocytes are the primary cell type responsible for synthesis of apoE, although microglia 




for CNS development and plasticity because neurons themselves only produce enough 
cholesterol for survival. They require apoE-mediated delivery of cholesterol for repair 
and synapse formation.307,308 ApoE is encoded by the APOE gene, which occurs as three 
alleles in the human population each differing by single cysteine-arginine substitutions. 
The alleles are designated as 2 (cys112, cys158), 3 (cys112, arg158), and 4 (arg112, 
arg158) .309  
In the 1990’s, the 4 allele gained notoriety as a major risk factor for sporadic 
Alzheimer’s Disease (AD).310–312 This discovery provided the impetus for numerous 
studies during subsequent decades that revealed apoE4’s association with pathological 
hallmarks of AD such as amyloid beta plaques and neurofibrillary tangles.313–315 The 4 
allele, which is expressed in anywhere from 14%-25% of the population, simultaneously 
increases the risk of developing AD and decreases the age of onset in a dose-dependent 
manner.310,316–318 In addition to its role in exacerbating AD pathology, the presence of 
apoE4 has also been associated with deficits in synaptic plasticity and cognitive function 
in a variety of other disorders and dementias.319–322 
Throughout development, synaptic pruning refines the circuitry of the CNS. Some 
synapses are strengthened, while other are phagocytosed, depending upon their level of 
activity. Astrocytes play a crucial role in the phagocytosis of unneeded synapses.323 
However, the apoE isoforms differentially modulate this astrocytic function, with E2 
enhancing and E4 decreasing phagocytosis and pruning compared to E3-expressing 
animals.324 This could explain why apoE4 knock-in mice display deficits in synaptic 
functioning even at a young age.325 Deficiencies in synaptic functioning in E4 animals 




Compared to neurons expressing apoE3 or E2, those expressing human E4 sequester 
AMPA and NMDA receptors intracellularly. This sequestration is possibly due to an 
apolipoprotein E receptor 2 (Apoer2)-mediated decrease in receptor 
phosphorylation.326,327  
 ApoE genotype also influences synaptic integrity through altering the influx of 
calcium ions. Expression of the apoE4 protein increases influx of extracellular calcium, 
inducing neurotoxicity in vitro.328 This excessive calcium influx could also be responsible 
for the increased in calcineurin activity in the cortex of apoE4 targeted replacement mice, 
which results in a loss of dendritic spines density.329 In contrast with evidence supporting 
the presence of excessive intracellular calcium in E4 neurons, a lack of Ca2+-mediated 
signaling in hippocampi of E4 animals is also evident.330 Impairment of signal 
transduction through CaMKIIa (Ca2+/calmodulin-dependent protein kinase IIa) and p-
CREB (phosphorylated cAMP response element-binding protein) impairs synaptic 
plasticity in rats injected with human E4 protein.330 Together, these results suggest that 
apoE4-dependent influences on Ca2+ signaling may be region-dependent within the CNS, 
making it difficult to predict how intracellular Ca2+ levels may be impacted in the spinal 
cord.  
 The detrimental effects of apoE4 on synaptic plasticity have functional 
consequences. Long term potentiation in the dentate gyrus is attenuated by the E4 
isoform.331,332 Mice expressing human apoE4 have deficits in learning, retention, and 
spatial memory.333–335 Deficits in learning and memory are more pronounced in females, 
as observed in targeted replacement mouse models that express human APOE 




mice are also evident in the human population. Individuals who have at least one E4 
allele display deficits in episodic memory and exhibit a decline in cognitive function over 
time.338–340  
 In addition to its role in neural development and cognitive functioning, apoE is 
also involved in repair processes following neurotrauma in the CNS and the 
periphery.341–343 These processes include neuroprotection, axon regeneration, and 
synaptogenesis, all of which are impaired in apoE4 mice following CNS insult.344–346 
Indeed, the 4 allele has been associated with worse outcomes in individuals who 
experience traumatic brain or spinal cord injuries.347–349 Studies of traumatic brain injury 
reveal that apoE4 delays repair of the blood brain barrier, exacerbates ischemic damage, 
and impairs plasticity in the form of learning and memory.350–352 Less is known about the 
impact of APOE genotype on plasticity of neural circuits after spinal cord injury, 
although studies in knockout mice have emphasized that apoE protein is crucial for white 
matter sparing and functional recovery after SCI.341,353,354 Data from our lab provides 
evidence that apoE4 animals exhibit attenuations in spinal and respiratory plasticity both 
in the absence and presence of cervical spinal cord injury.  
 
1.3.5 Sex as a biological variable in SCI research 
A crucial variable that accounts for much of the heterogeneity in the human 
population but is often not modeled preclinically is sex. Prior to 2009, the majority of 
preclinical biomedical research was performed in males, with only 15% of studies solely 
focused on females. Publications that did feature experiments in which both sexes were 




data from males and females.355  This led to incomplete understanding of disease 
pathologies and the therapeutic potential of drugs, with women suffering from unforeseen 
drug-related health risks as a result.356 In response to this issue as well as the 
reproducibility crisis, the National Institutes of Health developed policies in 2014 that 
require grant applicants to include both male and female subjects in their studies unless it 
can rigorously be proven unwarranted.357,358 
Studies addressing sex differences in nervous system structure and function have 
revealed that sex hormones impact CNS inflammation, neuronal dendrite morphology, 
and synaptic plasticity.359–362 Sex differences are also evident in the prevalence and 
manifestation of affective disorders including depression and post-traumatic stress 
disorder.363–365 These disparities indicate that the functioning, or malfunctioning, of 
neural circuits is strongly modulated by sex. Males and females also report different 
symptoms after traumatic brain injury, with females often experiencing increased anxiety 
and depression while males display enhanced aggression.366,367 When compared to males, 
improved functional outcomes have been observed in females who experience a 
neurotraumatic even, possibly due to protective effects of estrogen and progesterone.368–
370 
While little is known about the influence of sex on synaptic plasticity after SCI, a 
series of investigations by Zabka et al. revealed that sex hormones influence 5-HT-
dependent plasticity in the spinal cord.371–373 For example, gonadectomy abolishes LTF in 
male rats, but can be restored through administration of testosterone, which undergoes 




increasing 5-HT levels in the raphe while progesterone acts as a breathing stimulant.374–
376  
Interestingly, sex effects on CNS plasticity have also been observed in the context 
of the three APOE variants. Brain plasticity in the form of learning and memory is 
impaired in mice expressing the 4 allele, an effect that is more severe in females.336 
Until now, the manner in which sex and APOE genotype interact to influence plasticity 
and recovery of function after SCI has remained uninvestigated. However, conclusions 
from previous studies collectively emphasize the importance of considering both sex and 
genetic background when developing treatment strategies for the diverse spinal cord 
injured population since individuals may be predisposed toward or against plasticity and 
functional recovery. Indeed, a recent review from Fouad et al. emphasized the importance 
of considering variation in the human population and the response to therapeutics as a 
key to improving translation.377 Current work in our lab has aimed to address this gap in 
knowledge and provides novel insight into the interplay of sex and the human APOE 





CHAPTER 2. HUMAN APOE AS A BARRIER TO RESPIRATORY MOTOR 
PLASTICITY IN RATS 
2.1 Introduction 
 The majority of spinal cord injuries (SCIs) occur at the cervical level. 2 These 
high-level injuries can disrupt axons that descend from the brainstem to synapse on 
phrenic motor neurons (PMNs) at the C3-C6 level. PMNs control the contraction of the 
diaphragm, which is the primary muscle responsible for breathing function, and damage 
to these bulbospinal pathways leads to significant breathing impairments. As a result, 
cervically injured individuals who do not achieve sufficient spontaneous recovery 
become reliant on artificial ventilation, increasing their risk for respiratory infections and 
death after injury. Indeed, the restoration of independent breathing function is a top 
priority for the SCI community.378  
 Therapeutic approaches that are being developed preclinically with the goal of 
improving breathing function after SCI are plentiful and diverse, yet clinically available 
therapeutics are extremely limited. Currently, the primary commercially available method 
of restoring diaphragmatic function is surgical implantation of diaphragm pacers.190 Less 
invasive approaches to improve motor function, such as transcranial magnetic stimulation 
and intermittent hypoxia (IH) often work through a mechanism of modulating plasticity 
in the spinal cord to induce lasting changes in neural circuitry function.266,288,379 However, 
preclinical investigations into the efficacy of these strategies often utilize homogenous 
populations of animal models that are incapable of reflecting the diversity found in the 
human population. Therefore, the question of how plasticity in the spinal cord may be 




diversity could constitute a major confounding factor in clinical studies. For example,  
when therapeutics which show preclinical efficacy are advanced into clinical trials only 
to show conflicting or variable results. Ultimately, genetic variation could contribute to 
the lack of bench to bedside translation for the SCI population. 
 One well-described form of plasticity that has been validated to restore function to 
the paralyzed diaphragm after cervical SCI is long term facilitation (LTF). LTF can be 
induced through exposure to intermittent hypoxia (IH), which activates BDNF (brain-
derived neurotrophic factor)- and glutamate receptor-dependent synaptic 
strengthening.268,380 While LTF was first described as a prolonged augmentation of 
respiratory activity in intact animals, it was later discovered that it is also sufficient to 
improve diaphragm function in spinally injured animals.139,224,247 In addition to 
respiratory LTF, IH also induces plasticity in other motor systems. Indeed, IH has been 
utilized in clinical trials as a therapeutic approach to improve hindlimb, forelimb, and 
ventilatory outcome in SCI populations.140–142 Despite consistent preclinical findings, 
clinical studies have demonstrated that up to one-third of patients are “non-responders” to 
IH, meaning that they show no benefit from treatment.141,381 This indicates that factors in 
the human population, which are not represented in preclinical animal models, may limit 
the propensity for plasticity in some individuals, thereby reducing the potency of IH as a 
therapeutic tool. 
 The vast majority of preclinical investigations of the respiratory response to IH 
have been performed in rats. This has advantageously allowed for the optimization of IH 
protocols and provided a thorough understanding of the molecular mechanisms behind 




HT)-dependent, MacFarlane and Mitchell (2009) demonstrated that LTF can also be 
induced through episodic 5-HT dosing of the spinal cord. Unfortunately, the dependence 
on rat models of LTF limits the potential for studying the influence of human genetic 
diversity on this plasticity. To circumvent this deficiency while still utilizing a well-
characterized rat model of respiratory motor plasticity, the current study applies 
exogenous human apolipoprotein E (apoE) proteins directly to the spinal cord prior to 
episodic 5-HT dosing to determine how different isoforms of a human protein could alter 
spinal plasticity both in the presence and absence of cervical SCI.  
Of the three isoforms of apoE, designated E2, E3, and E4, the E4 isoform has 
previously been associated with impaired synaptic plasticity. The E3 and E4 isoforms 
(encoded by the 3 and 4 alleles of the APOE gene) are much more prevalent than E2, 
which is only present in around 7% of the human population.318 Therefore, the E3 and E4 
isoforms of apoE are ideal targets to test whether genetic factors in the human population 
may limit individuals’ propensity for plasticity, and consequently reduce the efficacy of 
therapeutic approaches that harness spinally-mediated plasticity as a means of improving 
functional recovery after SCI. We hypothesize that rats dosed with human apoE4 will 
display an abatement in respiratory motor plasticity, emphasizing the importance of 
considering human genetic diversity when developing and translating SCI therapeutics.  
2.2 Materials and methods 
 
2.2.1 C2 Hemisections 
All experiments were approved by the Institutional Animal Care and Use 




were obtained from Envigo (Indianapolis, IN). Animals were acclimated for at least one 
week before injury C2 hemisection. Prior to surgery, rats were anesthetized with 
ketamine (75-100mg/kg, Ketaset, Zoetis) and xylazine (5-10 mg/kg, AnaSed, Akorn 
Pharmaceuticals). When the proper plane of anesthesia was reached, the surgical site was 
shaved and sterilized with alternating 70% ethanol and betadine swabs. Puralube 
ophthalmic ointment was applied to the eyes to prevent drying during surgery. A skin 
incision was made on midline, extending from the ears to the level of the scapula. An 
incision was then made through the acromiotrapezius, semispinalis capitus, and rectus 
capitus muscles along the midline and muscles were retracted. Paravertebral musculature 
wass cut away from the C2 vertebra. A C2 laminectomy was performed by cutting the 
pedicles of the C2 vertebra bilaterally. The dura was perforated and resected using 
microscissors. The tip of a 27 gauge needle was bent at a 45 degree angle. Under a 
dissecting microscope, the needle tip was then inserted at the midline of the spinal cord at 
the C2 level, caudal to the C2 dorsal roots, and a cut was made extending from midline to 
the lateral edge of the cord. The needle was passed through the spinal cord in the same 
location for a total of three passes to ensure lesion completeness. Musculature was 
sutured with 6-0 absorbable suture and skin was closed with wound clips. Rats received 
subcutaneous buprenorphine (0.05mg/kg) and carprofen (5mg/kg) immediately as they 
began regaining consciousness.  
 
2.2.2 Chronic Spinal Cord Exposures and Episodic Serotonin Dosing 
Episodic 5-HT dosing was performed 20 weeks post-injury in C2 hemisected 




hemisected rats. Animals were anesthetized with urethane (1200mg/kg) intraperitoneally. 
An incision was made through the skin on the dorsal aspect of the neck as previously 
described for a C2 hemisection. Musculature and scar tissue were removed to expose the 
spinal cord at the C2/C3 level and a durotomy was performed with microscissors. Once 
the spinal cord was exposed, animals were moved into a supine position and a 
laparotomy was performed by incising the rectus abdominis, external oblique, and 
internal oblique muscles. Bipolar electrodes, connected to an amplifier and data 
acquisition system (CED 1401 with Spike2 Data Analysis Computer Interface, 
Cambridge Electronic Design), were inserted into the left and right hemidiaphragm and 
ground electrodes were inserted into the hind paws. Abdominal muscles were sutured and 
the animal was returned to prone position. 
 With animals in prone position, 20ul of apoE protein (1g/ml in physiological 
saline, optimal concentration was determined by preliminary studies, data not shown) 
was applied to the spinal cord. After 30 minutes, the apoE solution was swabbed from the 
spinal cord and 6ul of 5-HT (1M in apoE solution, as described by MacFarlane and 
Mitchell, 2009) was applied to the spinal cord. After 5 minutes, the first dose of 5-HT 
was absorbed with a swab and the second dose was applied. This was repeated for a total 
of three doses (Figure 1 B). Diaphragmatic activity was recorded for 40 minutes after the 
final 5H-T dose. Animals were then perfused with 4% paraformaldehyde (PFA) and the 
spinal column was removed and placed in 4% PFA at 4C. After 2 days, spinal columns 





2.2.3 Diaphragmatic EMG trace analysis 
After recording, raw diaphragmatic EMG traces were rectified and integrated 
using Spike2 software. Analysis was performed at six time points: twice during baseline 
recording, once 5 minutes before the final 5-HT dose, and at 5, 20, and 40 minutes after 
the final 5-HT dose (Figure 2.1 B). For each time point, peak amplitude was averaged 
over a 30 second period. Amplitude of diaphragmatic bursts at each time point were 
normalized to that animal’s pre-hypoxia baseline amplitude. Baseline amplitude was 
calculated by averaging the amplitudes quantified at 10 minutes and 5 minutes before the 
first dose of 5-HT. 
 
2.2.4 Labeling of phrenic motor neurons 
Labeling of PMNs was performed as previously described by Mantilla et al. 383 
Briefly, three days prior to terminal EMG recordings, animals received bilateral 
intrapleural injections of recombinant cholera toxin subunit B (CTB) conjugated to 
AlexaFlour 488 (Invitrogen, C22481). CTB was diluted in physiological saline to a 
concentration of 0.2%. Animals were anesthetized with isoflurane. The ventral thoracic 
region was shaved and swabbed with 70% ethanol. Using a Hamilton syringe, 20l of 
diluted CTB was injected in each the left and right sides of the thoracic cavity at a depth 
of 6mm from the skin. 
 
2.2.5 Sectioning and Immunohistochemistry 
 Spinal cords were dissected out of the spinal columns and embedded in Optimal 




cryosectioned at a thickness of 30m and placed directly onto slides. For the injury site 
(C2), every other section was collected. For the region of the phrenic motor nucleus (C3-
C6) every section was collected serially onto 10 slides so that every slide held sections 
from each spinal cord level. Sections from the C3-C6 were then labeled with antibodies 
for synaptophysin (Invitrogen 50-6525-82, diluted 1:32) and either GluR1 (Abcam 
Ab31232, diluted 1:500) or NR1 (Abcam 52177, diluted 1:100). Antibodies were diluted 
in blocking buffer (5% normal goat serum, 0.1% bovine serum albumin, and 0.1% triton-
X100 in 1xPBS). Slides were mounted with Flouromount (Southern Biotech, cat No. 
0100-20) and immediately sealed with clear nail polish. 
 
2.2.6 Imaging and Colocalization Analysis 
 Imaging was performed on a Nikon Eclipse Ti series inverted confocal 
microscope at 20x. For staining quantification in tissue from uninjured animals, 
snapshots of phrenic motor neurons were captured at the C4 level of each animal. For 
quantification in injured animals, Z stacks (2.19m per step) of phrenic motor nucleus 
were taken at the C4 level both ipsilaterally and contralaterally to injury. Investigators 
were blinded to genotype during imaging and quantification.  
 For colocalization analysis, images were opened in ImageJ (National Institutes of 
Health). Investigators were blinded to treatment and injury status until after quantification 
was complete. A region of interest was drawn around each phrenic motor neuron labeled 
by CTB. Colocalization was quantified through the “colocalization threshold” plugin. 
The Costes method for statistical significance was used to calculate Pearson’s correlation 




colocalization was real (ImageJ, “Colocalization Analysis”, 2020). To determine the 
percentage of synaptic glutamate receptor subunits compared to total subunits in each 
PMN, the number of colocalized voxels was then normalized to all voxels that were 
positive for NR1 or GluR1 in the region of interest. 
 
2.2.7 Quantitative PCR 
Fresh spinal cord tissue was collected from a cohort of animals for mRNA and 
protein quantification. These animals were sacrificed 1 hour after the final dose of 5-HT 
and the region of the phrenic motor nucleus (C3-C6) was excised and immediately frozen 
on dry ice. Tissue was kept at -80C until analysis was performed. The tissue was then 
divided for protein or RNA isolation, with 35-40mg of tissue being used for RNA 
extraction. Tissue was homogenized using a Bead Ruptor (Omni International). RNA was 
purified using an RNeasy Lipid Tissue Mini Kit (Qiagen, Cat #74804) and quantified by 
NanoDrop (ThermoFisher Scientific). Reverse transcription was performed in a Thermal 
Cycler (Bio-Rad) using 25ng/l of sample RNA. Quantitative PCR was performed on 
25ng of cDNA in a QuantStudio 7 (Applied Biosystems) using Luna Universal  Probe 
Master Mix (New England BioLabs, Cat #M3004S) and primers for BDNF 
(ThermoFisher, Rn01484924_m1) and actin (ThermoFisher, Rn00667869_m1). Fold 
change from vehicle-treated animals was then calculated for E3- and E4-treated animals.  
 
2.2.8 BDNF Quantification 
Remaining fresh tissue was homogenized in RIPA buffer (Alfa Aesar, J62524) 




quantified by a BCA assay (Pierce, Cat #23227). Protein was quantified using a Meso 
Scale Discovery UPLEX Assay (C0292-2).  
2.2.9 Statistical Analysis   
For statistical analysis of EMG traces, repeated measures (RM)-ANOVA was 
used to account for within-subject correlation given repeated measurements over time. 
Additionally, Student’s t-tests were performed at three time points (5 minutes before final 
5-HT, 5 minutes after final 5-HT, and 40 minutes after 5-HT) to determine whether there 
was a significant difference in diaphragmatic burst amplitude at any single time point. 
However, RMANOVA was the primary statistical analysis for this data. One injured 
apoE3-dosed rat was excluded due to its classification as a significant statistical outlier 
according to the Grubbs test. Two-way ANOVAs were used to analyze colocalization 
staining. Student’s t-tests were used to analyze qPCR and ELISA data. Results were 
considered statistically significant if p < 0.05. Investigators were blinded until all 
diaphragmatic EMG and histology analyses were complete.  
2.3 Results 
 
2.3.1 Respiratory motor plasticity in the presence of human apoE isoforms 
 Episodic 5-HT dosing of the cervical spinal cord is sufficient to induce LTF, 
which manifests as prolonged augmentation of breathing motor output.382 Utilization this 
method of induction, in contrast to exposure to IH using hypoxia chambers, allowed for 
simultaneous recordings of diaphragmatic EMGs. Human apoE protein in either the E3 or 
E4 isoform was applied intrathecally (1g/ml) to the exposed spinal cord at the C3-C6 




baseline diaphragmatic EMG recording in the presence of human apoE, rats received 
three doses of 5-HT (1M) separated by 5 minutes (Fig. 2.1 B). Diaphragmatic activity 
was recorded for 40 minutes after the final dose of 5-HT. Representative traces from E3 
and E4-treated animals are shown in Fig. 2.1 C. Quantification of burst amplitude 
demonstrated that there was no difference in the 5-HT-induced breathing changes 
between animals exposed to E3 and E4 protein (Fig 2.1 D,E). Time points for burst 
amplitude quantification are indicated by green arrows in Fig. 2.1 B.  
 
2.3.2 The influence of apoE isoforms on synaptic glutamate receptor levels 
 LTF is dependent upon activation of glutamate receptors on phrenic motor 
neurons.384,385 Because apoE4 is known to impair glutamate receptor trafficking326, we 
quantified the amount of synaptic AMPA and NMDA receptors on CTB-labeled phrenic, 
as previously described by Huie et al. (2015)203, motor neurons to determine whether E4 
would impede synaptic localization. Fig. 2.2 A-B shows representative images of 
colocalized staining of the synaptic marker synaptophysin and either the NMDA receptor 
subunit NR1 (A) or the AMPA receptor subunit GluR1 (B) on PMNs. Synaptic glutamate 
receptor subunits were normalized to the total amount of intracellular subunit staining. 
Quantification of synaptic NR1 and GluR1 demonstrated no significant difference 
between genotypes (Fig. 2.2 C-D, 2-way ANOVA, NR1 p=0.21 and GluR1 p=0.31). 
However, a trend emerged in which episodic 5-HT led to increases in synaptic 
localization of NR1 in rats exposed to E3 and E4 (Fig. 2.2 C). While a similar trend of 5-
HT-induced upregulation was observed in synaptic GluR1 in E3-treated animals, it was 




glutamate receptors in response to 5-HT suggests a potential apoE4-dependent deficiency 
in the ability to initiate synaptic plasticity. 
 
2.3.3 ApoE isoform-dependent modulation of spinal plasticity after SCI 
 In addition to enhancing breathing activity in intact rats, LTF also restores 
breathing function to the paralyzed hemidiaphragm after cervical SCI.139,247 To determine 
whether the impact of human apoE isoforms on spinally-mediated respiratory motor 
plasticity are altered by SCI, we performed episodic 5-HT dosing on C2 hemisected rats. 
In order to increase clinical relevance, we performed this 5-HT dosing protocol on 
animals that were chronically injured (20 weeks) when they received episodic 5-HT 
concurrently with terminal diaphragmatic EMG recordings. All rats in this study 
displayed spontaneous recovery of diaphragmatic recovery by 20 weeks post injury (data 
not shown). Fig. 2.3 A illustrates the lateral C2 hemisection injury model and depicts the 
resultant interruption of bulbospinal respiratory axons. As depicted in Fig. 2.3 B, our 
injury completely destroys the left half of the spinal cord at the C2 level. Diaphragmatic 
EMG recordings were performed concurrently with human apoE isoform administration 
and subsequent episodic 5-HT dosing as in intact animals. In contrast to intact animals, 
injured animals receiving apoE3 appeared to increase breathing activity after the final 
dose of 5-HT (Fig. 2.3 C). This is analogous to the effect observed in rats dosed with 
episodic 5-HT in the absence of human apoE.382 Although injured apoE4-treated animals 
did not exhibit a similar augmentation in breathing, there was no statistically significant 
difference between groups (Fig. 2.3 D-E, RM ANOVA p=0.58). Diaphragmatic burst 




was no significant difference between amplitude in E3 and E4 animals at this time point 
(Fig. 2.3 E, Student’s t-test p=0.27). 
 
2.3.4 Synaptic glutamate receptor expression on phrenic motor neurons after SCI 
 Similar to the procedure performed on tissue from spinally intact rats, tissue 
harvested from C2 hemisected rats was stained for synaptophysin and either NR1 (Fig. 
2.4 A) or GluR1 (Fig. 2.4 B). Colocalization of these molecules was quantified on PMN 
that had been retrogradely labeled with CTB, then normalized to total glutamate receptor 
subunits in the cell. Quantification of NR1 colocalization revealed that there was no 
difference between E3 animals that did receive episodic 5-HT and those that didn’t (2-
way ANOVA, multiple comparisons with Tukey’s post hoc test p=0.97). In contrast, 5-
HT induced a significant reduction in synaptic NR1 levels in E4-treated animals (Fig. 2.4 
C, 2-way ANOVA, multiple comparisons with Tukey’s post hoc test p=0.0266). The 
pattern of synaptic localization of GluR1 in injured animals differed greatly from that of 
NR1. Episodic 5-HT dosing appears to upregulate the synaptic localization of GluR1-
containing AMPA receptors in E3 animals, although this trend did not reach statistical 
significance (Fig. 2.4 D, 2-way ANOVA, multiple comparisons with Tukey’s post hoc 
test p=0.075). Episodic 5-HT treatment did not lead to changes in synaptic GluR1 levels 
in animals with apoE4 (2-way ANOVA, multiple comparisons with Tukey’s post hoc test 
p=0.60). This supports the trend observed in spinally intact E4 animals, further 
insinuating that E4 prevents 5-HT-induced increases in GluR1 trafficking to the 




 To determine whether C2 hemisection alone stimulated changes in synaptic 
glutamate receptor levels, we also compared NR1 and GluR1 colocalization between 
intact and injured animals that did not receive episodic 5-HT dosing. Figure 2.4 E-H 
shows this quantification in E3 (E,G) and E4 (F,H) animals. In both E3 (E. Student’s t-
test p<0.0001) and E4 (F. Student’s t-test p<0.0001) treated animals, synaptic NR1 
colocalization significantly decreases after injury. However, synaptic GluR1 localization 
did not differ significantly between uninjured and injured animals treated with human E3 
(G. Student’s t-test p=0.29) or E4 (H. Student’s t-test p=0.41) protein. 
 
2.3.5 Influence of apoE isoforms on 5-HT-dependent BDNF production 
 Previous studies have shown that induction of LTF leads to production of new 
BDNF following 5-HT receptor activation.223,268 Since this BDNF synthesis and 
subsequent binding of its TrkB (tropomyosin receptor kinase B) receptor is necessary for 
LTF, we investigated whether BDNF production differs between E3- and E4-treated 
animals. In uninjured animals, presence of human apoE3 or apoE4 did not appear to 
influence BDNF synthesis at either the mRNA or protein level in the region of the 
phrenic motor nucleus (Fig. 2.5 A,C, Student’s t-tests, mRNA p=0.73, protein p=0.69).  
Likewise, mRNA and protein quantification in tissue harvested from injured animals 
exposed to episodic IH revealed no significant difference between animals treated with 
E3 and E4 (Fig. 2.5 B, D, Student’s t-tests, mRNA p=0.83, protein p=0.43). Comparison 
of vehicle-treated animals that did not receive human apoE protein prior to episodic 5-HT 
dosing demonstrated no significant difference between BDNF mRNA expression in intact 




episodic 5-HT did not induce the expected increase in BDNF levels in hemisected 
animals, this was not due to an injury-induced ceiling effect on BDNF production. 
2.4 Discussion 
 Harnessing neural plasticity in the spinal cord by strengthening synaptic 
connections or activating spared latent pathways can provide a means of improving 
functional recovery after spinal cord injury. While therapeutic approaches that enhance 
neuroplasticity have proven effective in homogenous populations of preclinical rodent 
models, the impact of genetic variation in the diverse human population remains 
underexplored. The current study represents the first investigation into how genetic 
variation may impact individuals’ predisposition towards neuroplasticity, and 
consequently, their response to treatment strategies after SCI. By utilizing a well-
described model of respiratory motor plasticity in rats, we were able to model the impact 
of the plasticity-limiting human apoE4 protein on serotonin-dependent recovery of 
breathing function after SCI. Contrary to our hypothesis, we did not observe significant 
differences in the respiratory response to IH between E3 and E4 treated animals. 
However, apoE4 did cause a decline in synaptic NMDA receptor levels, indicating that 
apoE isoforms modulate plasticity at the molecular level in PMN synapses or in 
intracellular signaling cascades that are activated by therapeutic IH or episodic 5-HT. 
 
2.4.1 Human apoE isoforms and plasticity in the neural control of breathing 
 Long term facilitation of respiratory activity was first discovered as a result of 
carotid sinus nerve or carotid body afferent stimulation.386 This plasticity can also be 




exposure consists of repeated bouts opposed to a single, sustained hypoxic period.387 
Both electrical and hypoxic stimulation of carotid body afferents induce respiratory 
motor plasticity through serotonin-dependent mechanisms that result in strengthening of 
synaptic inputs onto PMNs.217,224,388 Indeed, directly administering episodic doses of 5-
HT directly to the cervical spinal cord of rats activates LTF through a mechanism similar 
to that of IH.382 However, episodic 5-HT in animals that had human apoE3 or E4 protein 
present in the cervical spinal cord did not induce augmentation of breathing motor output 
that is typically characteristic of LTF. 
The lack of LTF observed in apoE-treated rats could be due to a variety of factors. 
The original studies that describe LTF of breathing utilized animals that were 
vagotomized and artificially ventilated to maintain phrenic activity at the level that would 
be present during eupneic breathing. This was accomplished through monitoring pCO2, 
which created a feedback loop with the ventilator to preserve eupneic activity levels. 
Exhaled CO2 and body temperature were also monitored to control for changes in 
metabolic rate, cardiac output, and resulting CO2 return to the lungs.
386,389 While rats in 
the present study were kept on heating pads throughout IH and diaphragmatic EMG 
recordings, body temperature and CO2 levels were not monitored. As a result, animals 
may have experiences hypoxia-induced metabolic adjustments or vagal feedback that led 
to changes in breathing, which could negate the induction of LTF. 
Apolipoprotein E is a prominent protein of interest in the Alzheimer’s Disease 
(AD) literature, due to its designation as a significant risk factor for developing AD in 
people who express the apoE4 isoform. As a result, thousands of publication have 




studies have examined its role in spinal cord repair and recovery of function after SCI. 
Interestingly, spinally injured individuals who are apoE4+ exhibit less motor recovery 
than those who don’t carry the allele encoding E4.348,390 Although mouse studies have 
revealed that apoE levels in the spinal cord are elevated for up to three weeks post-injury, 
it is unknown how the distinct human isoforms may influence recovery or the response to 
therapeutics such as IH after SCI.341,391 While our data indicates that there is no 
difference in the response to episodic 5-HT between E3 and E4-treated animals, there are 
some methodological considerations to be addressed. The cervical spinal cord was bathed 
in human apoE protein for 30 minutes prior to episodic 5-HT. However, it is unknown 
whether apoE penetrated the cord sufficiently to reach PMN in the ventral horn. 
Additionally, apoE could have been interacting with various cell types in the spinal cord 
including astrocytes, microglia, and interneurons to influence signaling in the spinal 
circuitry. Rats were also still producing the rat form of apoE, which may have been 
competing with the exogenous human isoforms for receptor binding. These uncontrolled 
circumstances could have dampened the effect of the human isoforms in the spinal cord.  
The human apoE proteins used in these experiments were unlipidated. ApoE 
functions as a lipid carrier in the CNS and is lipidated by the ABCA1 (ATP binding 
cassette A1) transporter. ABCA1 transports cholesterol and phospholipids into HDL-like 
molecules that contain apoE.392 Lipidated apoE then binds its receptors such as LDLR 
(low density lipoprotein receptor) or apoer2.393,394 Because the different isoforms of apoE 
are known to have different lipidation profiles and also display isoform-dependent 
interactions with apoE receptors, the lack of lipidation may have altered or inhibited the 




CNS.395–397 To address these methodological concerns, we have performed additional 
studies in targeted replacement APOE mice, which express the human APOE alleles 
instead of the murine form under the control of the mouse promoter, allowing the animals 
to produce physiologically relevant lipidated human apoE protein for the duration of their 
lives, including during the recovery period following SCI.398–400  
 
2.4.2 The influence of human apoE on plasticity in the injured cord 
 The restoration of breathing function after SCI is crucial to limit hospital costs 
and lengths of stay, increase life expectancy, and decrease the occurrence of 
comorbidities such as respiratory infections.179,401,402 Intermittent hypoxia is therefore an 
intriguing therapeutic approach because it not only enhances spinally-mediated plasticity 
for the improvement of respiratory motor function, it also modulates plasticity in other 
motor systems. IH has undergone clinical trials with positive outcomes for ventilation, 
hand function, and ankle strength.140,142,403,404 However, subjects demonstrate varied 
responses to IH treatment, with some demonstrating notable functional improvement 
while others appear unaffected or even exhibit a slight decline in function.141,381 While 
the heterogeneous nature of SCIs could account for some of this variability, genetic 
variability that isn’t represented in preclinical animal models could also interfere with 
individuals’ capacity to respond to therapeutic approaches that stimulate plasticity of 
spinal circuits. 
 In support of this hypothesis is the emergent trend in C2 hemisected animals that 
were exposed to human apoE isoforms. While those treated with E3 displayed the 




had no change in breathing activity. Although this trend did not reach significance, it 
indicates that the human apoE isoforms may have a role in modulating respiratory motor 
plasticity. ApoE4 has gained notoriety for impairing synaptic plasticity in the brain, but 
this is the first investigation to find similar effects in spinally-mediated forms of 
plasticity.331,405 The dosing strategy utilized in this study had been previously described 
in rats by MacFarlane and Mitchell (2009). However, since both human apoE protein and 
5-HT were applied as solutions to the dorsal surface of the exposed spinal cord, there 
could have been inter-animal variation in the diffusion patterns of these molecules, 
explaining the variation observed between animals that prevented our data from reaching 
statistical significance. Future studies utilizing targeted replacement APOE mice will 
nullify this concern by ensuring that human apoE is expressed equally under the same 
promoter in all animals. 
 
2.4.3 Synaptic glutamate receptor levels on PMN after exposure to human apoE 
Although statistically significant differences in the diaphragmatic activity of E3 
and E4 animals were not observed, this does not rule out the possibility that the human 
apoE isoforms influences synaptic plasticity through a mechanism that isn’t robust 
enough to be observed in EMG recordings. LTF is induced through a signaling cascade in 
PMN that relies on newly synthesized BDNF signaling through the TrkB receptor, 
ultimately leading to phosphorylation and trafficking of glutamate receptors to the 
postsynaptic membrane.268,288 These postsynaptic glutamate receptors are crucial for 
synaptic strengthening of synaptic inputs on PMN and are necessary for the induction and 




therefore indicate a deficiency in the ability to induce spinal plasticity. ApoE4 is known 
to decrease trafficking of both AMPA and NMDA receptors, leading to deficits in 
synaptic plasticity.326 By utilizing a colocalization staining method described by Huie et 
al. (2015), we found that uninjured animals displayed no difference in synaptic AMPA or 
NMDA receptor subunit levels, regardless of apoE isoform or episodic 5-HT exposure. 
However, our data did indicate that 5-HT dosing led to slight increases in NR1 synaptic 
localization in both E3 and E4 animals, but only increased GluR1 in those with E3. 
Interestingly, although E4 animals did not demonstrate a similar increase in GluR1 after 
episodic 5-HT, they did have higher levels of GluR1 in the absence of 5-HT. Thus, the 
absence of GluR1 upregulation could indicate a ceiling effect on synaptic AMPA 
receptors, perhaps to compensate for the reduced dendritic spine density and loss of 
synaptic integrity that has been associated with apoE4.329,407 
Glutamate receptor localization after C2 hemisection differed greatly from that 
observed in intact animals. Both E3- and E4-treated animals downregulated synaptic 
localization of NR1 after injury. Perhaps more striking was the finding that episodic 5-
HT dosing caused a significant decrease in synaptic NMDA receptors when apoE4 was 
present. Since LTF requires signaling through NMDA, but not AMPA, receptors, this 
loss of postsynaptic NMDA receptors could contribute to the effect of E4’s dampening 
effect on the respiratory response to IH in injured animals. NMDA receptors (NMDAR) 
are heterotetramers composed of NR1, NR2, and NR3 subunits.408 While NR1 is an 
obligate subunit of functional NMDA receptors and therefore indicative of total 
NMDARs present, future investigations into the synaptic presence of additional NMDAR 




apoE isoforms. For example, previous work has shown that synaptic strengthening in the 
form of cortical long term potentiation relies on NR2A-containing NMDAR.409 Similarly, 
spinal cord plasticity leading to spontaneous recovery of breathing function and 
activation of the crossed phrenic pathway (the spared anatomical substrate mediating 
LTF after C2 hemisection) correlates with NR2A levels on phrenic motor neurons.410,411  
Subunits of AMPA receptors, GluR1 , 2, 3, or 4, also have unique impacts on 
synaptic signaling and plasticity, particularly since the GluR2 subunit confers calcium 
impermeability.412 Decreases in GluR2 after SCI are associated with synaptic 
strengthening mediated by calcium-permeable AMPA receptors.411,413 However, 
respiratory drive to PMN is communicated through glutamatergic bulbospinal pathways, 
emphasizing the importance of synaptic AMPAR expression.414,415 Accordingly, in 
response to SCI, GluR2 subunits decline as levels of the GluR1 subunit rise, although the 
increase in GluR1 after SCI in our apoE-treated animals did not reach statistical 
significance.411 Due to the different signaling properties conferred by various NMDA and 
AMPA receptor subunits and their role in modulating plasticity, further studies are 
needed to determine how additional subunits are altered in E3- and E4-treated animals. 
 
2.4.4 BDNF synthesis in response to episodic 5-HT 
 The differences observed in synaptic glutamate receptor localization following 
exposure to episodic 5-HT dosing between animals whose spinal cords had received 
apoE3 or E4 suggest that there could be apoE isoform-dependent influences on 5-HT-
induced signaling mechanisms upstream of glutamate receptor trafficking. Synthesis of 




of LTF.268 ApoE4 is associated with lower levels of BDNF in the brains of targeted 
replacement mice, making this step in the signaling cascade a likely candidate for 
apoE4’s inhibitory effect on synaptic glutamate receptor localization, and subsequent 
dampening of respiratory motor plasticity.416 Contrary to expectation, levels of BDNF 
mRNA and protein did not differ between spinal cord tissue from E3- and E4-treated rats. 
BDNF initiates downstream signaling through binding of its TrkB receptor.268 Although 
some evidence indicates that TrkB expression and kinase activity are attenuated by 
apoE4, other studies have suggested otherwise.416,417 Further investigation into the 
expression and activity of TrkB in the spinal cord of E3 and E4 animals may contribute to 
the understanding of the mechanism leading to loss of synaptic glutamate receptors that is 
associated with E4. 
 Through measuring diaphragmatic EMG recording and histological analysis, we 
show that the variant human isoforms of the apoE protein modulate plasticity in spinal 
circuits. Considering that many therapeutic approaches for SCI are developed to promote 
functional recovery by enhancing spinal plasticity, this data has important implications 
for how genetic diversity in the SCI population may influence individuals’ response to 
treatment strategies. Indeed, previously understudied factors such as APOE genotype 






Figure 2.1 Human apoE3 and E4 affect 5-HT dependent plasticity similarly.  
A. Schematic of the neural circuitry that mediates breathing. B. Timeline of the episodic  
5-HT dosing protocol with concurrent diaphragmatic EMG recordings. C. Representative 
diaphragmatic EMG traces illustrating breathing activity during and after episodic 5-HT. 
C. Quantification of diaphragmatic burst amplitude over time in response to episodic 5-
HT. There was no significant difference between animals exposed to E3 and E4 (RM 
ANOVA p=0.762). E. Quantification of diaphragmatic amplitude 5 minutes before and 
40 minutes after the final dose of 5-HT (Student’s t-tests E3xE4 5min before final dose 






Figure 2.2  ApoE4 prevents 5-HT-induced upregulation of synaptic AMPA receptors.  
A. Representative images of the C4 ventral horns with staining of synaptophysin (green) 
and NMDA receptor subunit NR1 (red) on labeled PMN (blue). Ventral horns are 
outlined in white. B. Representative images of synaptophysin (green) and the AMPA 
receptor subunit GLuR1 (red) on labeled PMN (blue). C. Quantification of the 
colocalization of synaptophysin and NR1. Neither E3 or E4 treated animals significantly 
increased synaptic NR1 in response to episodic 5-HT (2-way ANOVA p=0.21) and there 
was no difference between genotypes (2-way ANOVA p=0.868). D. Quantification of 
synaptic GLuR1 in the presence or absence of episodic 5-HT. Neither apoE isoform 
displayed a significant increase in synaptic GluR1 in response to episodic 5-HT (2-way 







Figure 2.3 ApoE4 is inhibitory to respiratory motor plasticity after SCI.  
A. Schematic of the left lateral C2 hemisection injury model and its impact on the 
breathing circuitry. B. Representative image of the rat spinal cord at the C2 level after C2 
hemisection stained with cresyl violet. C. Representative EMG traces from injured rats. 
Traces show activity of the hemidiaphragm ipsilateral to injury. Arrows indicate the 
timing of application of the three 5-HT doses. Dashed lines indicate baseline amplitude. 
D. Quantification of diaphragmatic burst amplitude in the left hemidiaphragm of injured 
animals in response to episodic 5-HT. There was no significant difference in the change 
in activity over time between genotypes (RM ANOVA, p=0.58). E. Quantification of 
diaphragmatic EMG amplitude 5 minutes before and 5 minutes and 40 minutes after the 
final dose of 5-HT (Student’s t-tests, E3xE4 5min before final dose p=0.83, E3xE4 5 min 








Figure 2.4 Human apoE4 decreases synaptic glutamate receptor expression after 
episodic 5-HT in hemisected animals.  
A. Representative images of staining for colocalization of  NR1 (red) and synaptophysin 
(green) on phrenic motor neurons labeled with CTB (blue). Ventral horns are outlined in 
white. B. Representative images of spinal cord sections with CTB-labeled PMN (blue) 
stained for GluR1 (red), synaptophysin (green). C. Quantification of synaptic NR1 
colocalized with synaptophysin normalized to total intracellular NR1. There was no 
significant difference between ApoE3 and E4 animals (a priori 2-way ANOVA 
p=0.0727). ApoE4-treated animals had significantly less synaptic NR1 in response to 
episodic 5-HT than those that did not receive 5-HT (a priori 2-way ANOVA and Tukey’s 
post hoc test p=0.0.0196). D. Quantification of colocalization of GluR1 and 
synaptophysin normalized to total cellular GluR1 in PMN. There was no significant 
difference between E3 and E4 (2-way ANOVA p=0.269). E3-treated animals exhibited a 
trend of increased synaptic GluR1 expression in response to 5-HT (2-way ANOVA and 
Tukey’s post hoc test p=0.075). E-H. Comparisons of synaptic glutamate receptor subunit 
levels in intact and C2 hemisected mice that did not receive 5-HT. In both E3 and E4 




and F. p<0.0001, respectively). Levels of synaptic GluR1 were not significantly different 
between intact and injured animals in the presence of either apoE isoform (G., apoE3 






Figure 2.5 BDNF expression isn’t apoE isoform-dependent.  
A,B. Expression of BDNF mRNA in the region of the phrenic motor nucleus in uninjured 
(A) and injured (B) rats. There was no significant difference between genotypes in the 
presence or absence of injury (Student’s t-test, uninjured p=0.73, injured p=0.83). C,D. 
Quantification of BDNF protein. There was no significant difference between genotypes 






Figure 2.6 Cervical SCI alone does not change BDNF levels in the phrenic 
motor nucleus. 
BDNF mRNA expression did not significantly differ between intact and C2 hemisected 





































CHAPTER 3. NOVEL INFLUENCES OF SEX AND APOE GENOTYPE ON SPINAL 
PLASTICITY AND RECOVERY OF FUNCTION 
3.1 Introduction 
Over 17,000 Americans experience a spinal cord injury every year.2 Depending 
on the level of injury, damage to neural pathways in the spinal cord can lead to a 
multitude of sensory deficits and loss of crucial motor functions. Over the past few 
decades, many promising therapeutic approaches have been developed to enhance 
neuroprotection or induce anatomical and functional plasticity of spinal pathways to 
restore function.139,418–421 Moreover, pivotal studies using nerve grafts, PTEN deletion, 
NOGO inhibition, or degradation of the perineuronal net or chondroitin sufate 
proteoglycans (CSPGs) have demonstrated that the CNS is capable of overcoming neural 
intrinsic and extrinsic barriers to regeneration after injury, leading to meaningful 
preclinical recovery.93,114,116,422,423 However, these therapeutic strategies have met with 
varied clinical success and there remains a lack of effective treatment strategies for the 
human SCI population.424 
A striking difference between individuals living with SCI and the animals used to 
model them is the level of genetic diversity represented in these populations. In contrast 
to the incredible diversity of the human population, preclinical studies typically utilize 
homogenous groups of animals with the same sex and similar genetic backgrounds. 
While this does facilitate easier determination of treatment effects, it also makes it less 
likely that discoveries in these models will translate to human patients. Although an 
increasing number of preclinical investigations are addressing how sex influences the 




unexplored. A recent review by Fouad et al. specifically outlined the importance of 
evaluating the influence of factors such as sex and genotype to address the 
neuroanatomical-functional paradox and lack of therapeutic translation in SCI.377 Indeed, 
we hypothesize that genetic factors could play a considerable role in determining how 
individuals respond to treatment strategies. 
Apolipoprotein E (ApoE) is a highly expressed lipid carrier in the CNS.303 It is 
encoded by the APOE gene, which exists in three common alleles designated 2, 3, and 
4. The 4 allele, which is carried by nearly 1 in 5 individuals, has been associated with a 
number of detrimental outcomes, including a weakening of synaptic plasticity in the 
brain.425 However, despite a robust body of literature in neurodegenerative diseases and 
traumatic brain injury347,350,426, the impact of 4 on plasticity in the spinal cord remains 
underexplored. We hypothesized that spinally-mediated plasticity is constrained in apoE4 
animals, thereby demonstrating the importance of considering the diversity of the human 
population when developing therapeutic approaches for people with SCI. 
To test this hypothesis, we utilize a model of cervical injury to examine how 
APOE genotype alters the response to intermittent hypoxia (IH). Most SCIs occur at these 
high levels and can disrupt the neural circuitry that mediates breathing, leading to 
respiratory insufficiency and potentiating the need for mechanical ventilation.2,427,428 
Mechanical ventilation increases the risk of respiratory infection, a leading cause of 
rehospitalization and death following cervical spinal cord injury (cSCI).402 
In recent years, there has been a growing appreciation for the potential of 




In clinical trials, therapeutic IH has been utilized to increase limb function and to 
facilitate ventilation in persons with SCI by enhancing plasticity in the spinal 
cord.140,142,381 Neural pathways in the cervical region which mediate breathing are critical 
therapeutic targets of IH, including spared pathways which might remain after injury. 
However, the influence of human genetic variability on IH-induced recovery is unknown. 
Therefore, we utilized this model of spinally-mediated plasticity to examine how 
expression of different human APOE alleles alter the efficacy of therapeutic strategies, 
such as IH, that are being developed to enhance plasticity following SCI. Our results 
provide evidence that both sex and APOE genotype determine the propensity for 
plasticity in humanized mice that are exposed to therapeutic IH. 
3.2  Methods 
This chapter of the Dissertation has been adapted from a manuscript published in 
eNeuro.429 
 
3.2.1 C2 Hemisections 
All experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Kentucky. Mice expressing human apoE isoforms under 
control of the mouse APOE promotor (targeted replacement mice) were backcrossed for 
at least 10 generations to the C57BL/6 background.398–400 Mice were group-housed on a 
twelve-hour light/dark cycle and fed normal chow diet ad libitum. All mice were 92-105 
days old at the time of injury. Female (20-24g) and male (22-30g) mice were anesthetized 
with isoflurane. Animals were then prepped for surgery by shaving the surgical area 




ophthalmic ointment was applied to the eyes to prevent drying during surgery. A midline 
incision was made through the skin just caudal to the ears to between the scapulae. 
Marcaine/bupivacaine was instilled along the incision site. The acromiotrapezius, 
semispinalis capitus, and rectus capitus posterior muscles were cut along their midline, 
bluntly dissected, and retracted. Paravertebral muscles were cut away from the C2 
vertebra using ToughCut Spring Scissors (Fine Science Tools). The lamina of the C2 
vertebra was then removed using Spring Scissors. Under a dissecting microscope (Meiji 
EMZ), a left lateral C2 hemisection (C2Hx) was performed by inserting a 27-gauge 
needle into the midline of the spinal cord at the C2 level and dragging the needle to the 
left lateral edge of the cord. This was then repeated once to ensure a complete injury. 
Musculature was sutured (6-0 absorbable suture) and skin was closed with Vetbond 
Tissue Adhesive (3M). Animals received subcutaneous buprenorphine (0.75mg/kg)  and 
carprofen (10mg/kg) immediately after surgery. Male mice were housed individually 
following surgery to prevent fighting amongst cagemates. 
 
3.2.2 Intermittent Hypoxia and Diaphragmatic Electromyography (EMG) 
Three weeks after hemisection, animals were anesthetized with isoflurane using 
the SomnoSuite Anesthesia System (Kent Scientific). A laparotomy was performed by 
cutting through the rectus abdominis, external oblique, and internal oblique muscles. 
Bipolar electrodes, connected to an amplifier and data acquisition system (CWE BMA-
400 Four-channel Bioamplifier, CED 1401 with Spike2 Data Analysis Computer 
Interface), were inserted into the dorsal region of the left hemidiaphragm, where they 




increased attrition rate we observed after performing bilateral electrode insertion. The 
laparotomy was also closed using Vetbond. Ten minutes of baseline breathing activity 
was recorded. The air input to the Somnosuite was then changed from room air 
(normoxia) to a tank of 11% oxygen, 89% nitrogen gas (hypoxia) for 5 min, at which 
point it was switched back to room air for 5 minutes. This was repeated for 3 bouts of 
hypoxia separated by 5 minutes of normoxia. Diaphragmatic activity was recorded for 1 
hour after the final hypoxic bout (Fig. 1 A). Although core temperature was not 
monitored during recordings, animals were kept on heating pads throughout all recording 
procedures to maintain body temperature. 
 
3.2.3 Sectioning and Staining  
To harvest tissue for immunohistochemistry, mice were perfused with 4% 
paraformaldehyde (PFA) following the diaphragmatic EMG recording. The spinal 
column was isolated and placed in 4% PFA at 4C. After two days, tissue was removed 
from PFA and placed in a 30% sucrose solution at 4C for cryoprotection until 
sectioning. 
Tissue was mounted and frozen in Tissue Plus O.C.T. Compount (Fisher 
Healthcare) and cut at a thickness of 20m on a cryostat (Leica). Serial sections from the 
injury site (C1-C2) were placed on one set of slides while serial sections from the level of 
the PMN (C3-C6) were placed on another set. Injured tissue slides were dehydrated in 
ethanol and stained with 0.1% Cresyl violet solution (Sigma Cat #C5042).  Slides were 
then mounted using permount (Electron Microscopy Sciences Cat #17986-01). For 5-HT 




blocked in a solution of 5% normal goat serum, 0.1% bovine serum albumin, and 0.1% 
TritonX-100 dissolved in PBS. Slides were incubated in 5-HT primary antibody diluted 
1:10,000 (rabbit, ImmunoStar Cat #20080) then goat anti-rabbit AlexaFluor488 
secondary antibody (1:500, Life Technologies Cat #A11034). Stained slides were 
mounted with ProLong Gold mountant with DAPI (Invitrogen Cat #P36931). For WFA 
(Wisteria Floribunda Lectin) staining, frozen sections were thawed to room temperature, 
washed with 1xPBS, then blocked in 3% normal goat serum diluted in PBS. Slides were 
then incubated in WFA primary antibody conjugated to Fluorescein at a dilution of 1:400 
(Vector Labs Cat #FL-1351). Stained slides were mounted in ProLong Gold with DAPI.  
 
3.2.4 Trace Analysis 
After recording, raw diaphragmatic EMG was rectified and integrated using 
Spike2 software. Analysis was performed at twelve time points: twice during baseline 
recording, once during each hypoxic and normoxic bout, and at 10, 20, 30, and 40 
minutes after the final hypoxic period (Figure 3.1 A). For each time point, peak amplitude 
was averaged over a 30 second period. Amplitude of diaphragmatic bursts at each time 
point were normalized to that animal’s pre-hypoxia baseline amplitude. Frequency of 
diaphragmatic bursts, indicative of breaths, was also quantified over a 30 second period 
at each time point. 
 
3.2.5 Imaging and image quantification 
Staining for cresyl violet and WFA was imaged on a Keyence BZ-X810 




using brightfield illumination at 2x. Sections stained for WFA were imaged at 10x using 
the monochromatic camera with high resolution (0.75488m/pixel) for quantification. 
Additional images for publication were acquired on a Nikon Eclipse Ti series inverted 
confocal at 40x, focused on the ventral horn in the region of the putative PMN. Sections 
stained for 5-HT were imaged on the Nikon at 20x. Images of 5-HT staining for 
publication were taken at 40x in the region of the PMN. All imaging and quantification 
was performed on the ventral horn of the left side of the cord, ipsilateral to the injury. 
WFA labeling was quantified using the HALO image analysis platform (Indica 
Labs). We developed and optimized an algorithm on the Area Quantification v1.0 to 
capture positive staining for WFA while omitting any nonspecific fluorescence. A region 
of interest (ROI) was drawn around the left ventral horn of sections at the level of C4. 
The quantification algorithm was applied to the ROI of each section. The area of staining 
was then normalized to the total area of the ROI. Three tissue sections at level C4 were 
analyzed for each animal. 5-HT labeling was also quantified with HALO. A region of 
interest was drawn around the left ventral horn. Serotonergic fibers within the ROI were 
traced using the embedded annotation tool. The total length of fibers was then normalized 
to the area of the ROI.  
 
3.2.6 Experimental Design and Statistical Analyses 
Sample sizes for mice receiving diaphragmatic EMG recordings were calculated 
based on preliminary data from 10 hemisected mice representing all three genotypes 
using Cohen’s D to estimate effect size (data in Table 3.2). Group sizes for each sex and 




and spinal cord tissue was harvested from these animals for IHC and quantification of 
WFA and serotonergic sprouting (apoE3 n=4, apoE4 n=5) 
For statistical analysis of EMG traces, repeated measures (RM)-ANOVA was 
used to account for within-subject correlation given repeated measurements over time. 
Stratified RMANOVA analyses were performed on male and female traces. Results were 
considered statistically significant if t1.96. Student’s t-test was used to analyze 5-HT 
fiber staining on spinal cord tissue. Welch’s t-test for unequal variances was used to 
analyze staining of WFA. Results were considered statistically significant if p < 0.05. 
Investigators were blinded until all diaphragmatic EMG and histology analyses were 
complete. The mean difference (MD) and 95% confidence interval (CI) were calculated 
to provide an estimate of the range of possible differences between groups. 
Table 3.1 Injured group sizes 
 
Male  Female 
E3 n=7 n=8 




3.3.1 Respiratory motor plasticity in C2 hemisected humanized APOE mice 
At 3 months of age, male and female mice received a left C2 hemisection by 
making an incision from the midline to the left lateral edge of the spinal cord just caudal 
to the C2 dorsal roots. This injury effectively disrupts the neural circuitry that descends 
from the ipsilateral medullary respiratory nuclei to phrenic motor neurons on the left side 




thorax of each mouse to ensure that only the right side of the thorax continued 
rhythmically expanding with each breath. Injury completeness was histologically 
confirmed upon sacrifice of a subset of mice (n=16) using cresyl violet (Fig. 3.1 C). All 
mice were homozygous for human 3 or 4 alleles expressed under control of the murine 
APOE promoter as described previously.398,400 At 3 weeks post-injury, mice were 
exposed to intermittent hypoxia. This consisted of 3 hypoxic (11% O2) bouts of 5 minute 
duration separated by 5 minutes of normoxia as illustrated in Figure 1. We evaluated the 
breathing response to IH by concurrently recording diaphragmatic EMG, which 
continued for 1 hour following the final hypoxic bout. Amplitude of diaphragmatic bursts 
was quantified while blinded and then grouped according to APOE genotype. No 
difference was found in the response to IH between mice expressing 3 or 4 (Fig. 3.1 D, 
RMANOVA p=0.741). All animals appear to experience an initial decrease in 
diaphragmatic activity during the first hypoxic bout. Breathing in both apoE3 and apoE4 
mice remained constant once the IH protocol ended (Fig. 3.1 D).  
Previous studies in rodents have shown that IH treatment gives rise to an 
augmentation of breathing activity that characterizes LTF.224,232,387,388 We therefore 
compared amplitude at the beginning of IH and 40 minutes after the final bout of hypoxia 
to determine whether breathing activity increased in response to IH. Neither genotype 
exhibited significant augmentation of diaphragmatic activity at 40 minutes post-hypoxia, 






3.3.2 Sex differences in APOE modulation of LTF 
To investigate sex-dependent influences of APOE genotype on LTF, we separated 
data from males and females for independent analysis. Animals were weighed every day 
for the first 4 days after injury and then once a week until diaphragmatic EMG recordings 
were performed. When comparing weights over time after injury, there was no significant 
difference between genotypes in male (p=0.16) or female (p=0.65) mice (data not 
shown). Figure 3.2 A shows representative traces from male apoE3 and E4 mice. As 
evidenced in these traces, both genotypes exhibited a decrease in frequency over time 
after IH. However, there was no significant genotype effect on the magnitude of this 
decrease (Fig. 3.2 A, supplementary Fig. 3.1 A, RMANOVA, p=0.846). Previous studies 
in rats have reported no spontaneous recovery in the paralyzed hemidiaphragm even 
chronically after C2 hemisection.218 In contrast, the overwhelming majority of the 32 
mice used in the current study showed spontaneous functional recovery of the paralyzed 
mouse hemidiaphragm. Considering all males and females from which we recorded 
diaphragmatic EMG’s, only 2 mice displayed no spontaneous recovery: 1 male of each 
genotype (Fig 3.2 B). Quantification of the diaphragmatic EMG data demonstrates that 
males expressing the 3 allele display a decline in the amplitude of diaphragmatic 
bursting beginning in the first hypoxic bout and persisting throughout the recording 
period (Fig. 3.2 C). Although this deterioration of activity did not reach statistical 
significance (RMANOVA, t=0.03), it is worthwhile to highlight how the apoE3 males 
diverged from apoE4, which demonstrate slightly heightened activity at 40 minutes post-




Analysis of diaphragmatic EMGs in female mice of both genotypes showed a 
similar negative trend in the breathing frequency induced by IH (Fig. 3.3 A, 
supplementary Fig. 3.2, RMANOVA, p=0.673). A subset of mice displayed a complete 
loss of diaphragmatic activity following hypoxic exposure. We refer to these animals as 
“non-responders”. Three non-responders emerged in the apoE4 group, while none were 
observed in the mice that expressed 3 (representative trace shown in Fig. 3.3 B). 
However, unlike the male mice, all females demonstrated spontaneous recovery prior to 
IH (data not shown). Quantification of diaphragmatic burst amplitude in females that 
maintained diaphragmatic activity after IH showed that apoE3 mice responded to IH with 
an initial decrease in burst amplitude. This decline was temporary and activity returned to 
near baseline levels by 40 minutes (Fig. 3.3 C). However, apoE4 females exhibited an 
immediate reduction in burst amplitude that is still evident the end of the recording 
period. At 40 minutes post-IH, breathing of apoE4 females is significantly depressed 
compared to that of apoE3’s at the same time point (Fig. 3.3 C,D, mixed model 
RMANOVA t=2.08). Consistent with the combined data, none of the female mice 
expressing human APOE developed the gradual and prolonged breathing augmentation 
that is characteristic of LTF. 
When animals are challenged with a brief bout of hypoxia, feedback from 
peripheral chemoreceptors induces an augmentation of respiratory output. This change in 
ventilation is known as the hypoxic ventilatory response (HVR).430 During the hypoxic 
bouts of IH treatment, all apoE mice exhibited a decline in diaphragmatic activity instead 
of the expected amplification. To further investigate the HVR in our humanized mice, we 




assessed the changes in amplitude and frequency of diaphragmatic bursting. No females 
of either genotype displayed an increase or decrease in amplitude, but breath frequency 
began to decline by the end of the hypoxic period in those expressing 4 (supplementary 
Fig. 3.2 B,C). In male mice expressing 3, there was a sharp decline in both amplitude 
and frequency of diaphragmatic firing in response to hypoxia such that breathing activity 
was abolished at 10 minutes. Conversely, amplitude and frequency in apoE4 males 
remained constant  during hypoxia (supplementary Fig. 3.1 B,C). 
3.3.3 Perineuronal net upregulation and serotonergic sprouting in the phrenic motor 
nucleus 
Secretion of chondroitin sulfate proteoglycans (CSPGs), a component of the 
perineuronal net (PNN), is upregulated after SCI in wild type animals, creating a barrier 
to plasticity, regeneration, and sprouting.422,431 Thus far, it is unknown if the magnitude 
of this upregulation is modulated by human APOE genotype. Therefore, we utilized WFA 
staining to compare the amount of PNN present in injured spinal cords at the C4 level to 
determine if the IH-induced reduction in diaphragmatic activity observed in E4 females 
was correlated with increased amounts of inhibitory PNN. Indeed, we found that apoE4 
females tended to have a higher density of WFA around the phrenic motor nucleus after 
injury, although this trend did not reach significance (Fig 3.4 A-C, Welch’s t-test, 
p=0.0697).  
The PNN can limit 5-HT sprouting after injury.422 To determine whether 
differences in respiratory motor plasticity observed in females were due to the amount of 
serotonin at the level of the phrenic motor nucleus after C2Hx, serotonergic fibers were 




after injury has previously been correlated with the restoration of breathing function and 
enhancement of LTF.247 We postulated that dampened respiratory plasticity in 4 females 
may be due to a lack of serotonergic sprouting after injury. Surprisingly, quantification of 
5-HT+ fibers ipsilateral to injury revealed enhanced serotonergic sprouting in apoE4 
females compared to apoE3 (Fig. 3.5 A-C Student’s t-test, p=0.0193). This contradicted 
our expectation that a blunted respiratory response to IH would correspond with 
attenuated fiber sprouting after injury. Quantification of 5-HT fibers contralateral to 
injury showed no significant difference between E3 and E4 females, although E4 tended 
to have more 5-HT staining (Fig. 3.5 D, Student’s t-test, p=0.286). After injury, E4 
females had more 5-HT fibers ipsilateral than contralateral to injury, although this did not 
reach statistical significance (Fig. 3.5 E, Student’s t-test, p=0.187). 
3.4 Discussion 
This study represents the first investigation into human genetic influences on the 
efficacy of experimental therapeutic strategies for SCI. Our results demonstrate that 
individuals’ propensity for initiating beneficial neuroplastic responses to therapeutic IH is 
modified by sex and apolipoprotein E genotype. By utilizing a well-described model of 
SCI and spinally-mediated motor plasticity, we provide evidence to support the 
hypothesis that human genetic factors that are not represented by preclinical animal 
models limit the potential for recovery after SCI. Our physiology and histology data 
indicate that sex and genotype influence the CNS response to injury and therapeutic 






3.4.1 APOE genotype and respiratory motor plasticity 
Recovery of breathing function is a top priority for people living with cervical 
SCI.378 Intermittent hypoxia has promising potential to enhance spinal plasticity for the 
restoration of a variety of motor behaviors, including breathing.139,404,432 Studies by 
Wadwha et al. (2008) and Tester et al. (2014) in human participants have demonstrated 
that ventilatory LTF is expressed by both male and female subjects, even when living 
with a chronic SCI. However, to our knowledge, the interaction of sex and genetic factors 
remains unexplored in the LTF literature. Preclinical studies that have addressed the 
impact of sex on respiratory motor plasticity revealed that sex hormone levels have 
significant ramifications for the potential to induce plasticity, likely due to the interaction 
of sex hormones and the serotonergic system.373,433,434 Additionally, Baker-Herman et al. 
(2010) found that rat strains of different genetic backgrounds vary in their responses to 
IH, which was associated with differences in the expression of 5-HT2A receptors on 
PMNs. 
To further address how genetic variability impacts spinal plasticity, we examined 
the efficacy of IH for inducing LTF in targeted replacement mice expressing the human 
APOE 3, and 4 alleles. Since APOE first gained notoriety as a genetic marker for 
Alzheimer’s Disease (AD), an extensive body of literature has investigated the impact of 
the apoE isoforms in the brain. The 4 allele increases the risk of developing AD and 
lowers the age of onset in a dose-dependent manner.310,312 E4 carriers display 
mitochondrial dysfunction, aggravated neuroinflammatory responses to CNS damage, 




also key determinants for the extent of tissue damage, plasticity, regeneration, and the 
potential for recovery after SCI.11,437–439  
APOE further became a gene of interest in our investigation after studies in 
human SCI patients found that people who carried the 4 allele experienced significantly 
less motor recovery than non-carriers, despite spending more time in rehabilitation.348,390 
ApoE4 is known to curb recycling of NMDA and AMPA receptors to the postsynaptic 
membrane and reduces levels of BDNF in the CNS.326,416,440 Since LTF requires BDNF 
signaling and activation of NMDA receptors, individuals expressing the 4 allele may 
have a constrained response to IH.268,384 However, our data demonstrates that mice 
expressing human apoE isoforms did not differ in their diaphragmatic response to IH, 
indicating that there may be no effect on LTF when APOE genotype is the sole variable 
being considered, 
The lack of divergence between genotypes and the absence of augmented 
diaphragmatic activity in response to IH could also be due to metabolic changes. Many 
protocols for the induction of LTF, which are primarily conducted in rats, include the 
measurement of pCO2 throughout recording.
221,224 This measurement provides a gauge of 
how metabolism is changing as a result of hypoxic hypometabolism: instead of increasing 
respiratory activity, small mammals respond to hypoxic conditions by downregulating 
their metabolic rate to reduce oxygen consumption.441 Because we did not measure pCO2 
during EMG recordings due to the low blood volume of mice, we were unable to control 
for changes in metabolic rate, which could have prevented IH-induced breathing 




masking genotype effects since differences emerged when animals were grouped 
according to sex. 
Interestingly, mice displayed a decrease in ipsilateral hemidiaphragmatic activity 
during hypoxic bouts, instead of the heightened activity that is typical of the HVR 
observed in rats.430 Very little data is available on the respiratory response to IH and 
manifestation of LTF in C2 hemisected mice, although Minor et al. (2006) demonstrated 
the presence and viability of the murine crossed phrenic pathway (CPP), the anatomical 
substrate that mediates LTF.247 The few studies performed in mice are variable in IH 
protocols and methods of assessing LTF.231–233 Our HVR data indicates that mice respond 
to bouts of hypoxia differently than rats, but further experiments are needed to 
characterize this phenomenon. Considering the availability of transgenic mouse models, a 
standardized protocol for inducing and evaluating LTF in murine models would be 
extremely advantageous for studying how human genes influence spinally-mediated 
breathing plasticity. 
3.4.2 Sex effects 
Another explanation for the lack of observable differences between genotypes is 
that they could be masked by sex effects. APOE has long been studied in the Alzheimer’s 
field, where genotype influences are known to be modulated by sex. While expression of 
the 4 allele increases the risk of developing AD in both males and females, this risk is 
greater in females.442,443 In rodents, apoE4-related deficits in learning and memory are 
aggravated in females, indicating that synaptic plasticity in the brain is impaired in a sex-




led to further analysis of our data, in which the influence of genotype was investigated 
separately in males and females. 
Diaphragmatic EMG recordings from females revealed a significant difference 
between the response of apoE3 and apoE4 animals. Forty minutes after IH, diaphragmatic 
activity was significantly depressed in females expressing 4. Consistent with findings in 
the brain, this demonstrates that apoE4 females have a limited propensity for plasticity in 
the spinal cord. This pattern was not reflected in male mice. In contrast with the current 
body of literature, we show that apoE3 males experience a barrier to synaptic plasticity, 
as they display the largest decrease in diaphragmatic activity. 
To our knowledge, apoE3-associated attenuations of plasticity have never been 
reported in young adult mice. Since the majority of apoE literature describes its effects on 
the brain and the periphery, it is possible that our results are due to a unique action of 
apoE in the spinal cord. The mechanism behind induction of LTF in the bulbospinal 
breathing circuitry is similar to that of long term potentiation (LTP) in the hippocampus: 
both rely on synaptic strengthening brought about by activation of postsynaptic NMDA 
receptors and signaling through ERK.384,445,446 Disparate results from a variety of studies 
in targeted replacement mice suggest apoE4 can be detrimental or beneficial to LTP 
depending on brain region, sex, and age.331,335,447,448 Taking this into account, it is less 
surprising to see that apoE3 also has the potential to augment or impede similar 






3.4.3 The inhibitory PNN and serotonergic presence after C2Hx in targeted replacement 
mice 
 Following SCI, there is a dramatic upregulation of inhibitory CSPGs at the site of 
injury and in denervated targets.99,422,449 Indeed, after dorsal column transections, there is 
an upregulation of the CSPG-containing PNN around sensory nuclei 449 and in previous 
studies utilizing lateral C2 hemisections, PMNs became further encased by CSPGs and 
the PNN.422 Despite the abundance of evidence implicating the importance of CSPGs in 
limiting plasticity, regeneration, and recovery (reviewed by Tran et al., 2018), the 
influence of human genetics (and APOE alleles) on PNN structure and neuronal sprouting 
in the injured spinal cord has never been investigated. However, a study of human brains 
indicated that apoE4 augments expression of a CSPG known as brevican in the brain of 
Alzheimer’s patients, which could explain the more extensive staining of PNN observed 
in E4 mice.451  
Indeed, our findings indicate that apoE4 females exhibit a greater density of the 
PNN in the ventral horn region containing PMNs after injury. Although PMNS were not 
discreetly labeled, upregulation of the PNN at the C4 level ipsilateral to injury suggests 
that deficits in respiratory motor plasticity could be a consequence of the PNN’s 
numerous influences on CNS function and plasticity. Appearance of the PNNs containing 
CSPGs during development ends critical periods in which experience-dependent 
plasticity shapes neural circuitry. Degradation of CSPGs reopens this critical period and 
restores synaptic plasticity in the adult CNS.452 Following lateral spinal hemisection, 
increasing densities of CSPG molecules impede calcium diffusion and block action 




also create an inhibitory microenvironment that prevents sprouting and regeneration of 
fibers in the injured spinal cord, including 5-HT fibers that have the potential to enhance 
functional recovery after experimental SCI.209,218,422 
Since serotonergic signaling at the level of PMNs is crucial to induction of 
LTF224, we quantified 5-HT staining around the putative PMN in spinal cords from E3 
and E4 females. Density of 5-HT fibers was higher in E4 females both contralateral and 
ipsilateral to injury, although this difference did not reach statistical significance on the 
contralateral side. This indicates that compared to apoE3, apoE4 females may have 
greater serotonergic innervation of the PMN in the absence of injury. However, 
additional studies are needed to determine whether females expressing 4 have greater 
serotonergic innervation prior to injury, as well as after C2Hx. Indeed, if this pattern is 
consistent regardless of injury status, increased 5-HT fiber density could represent a 
compensatory mechanism that maintains motor neuron excitability in these animals while 
combatting the loss of synaptic integrity over time that is observed in E4 animals.407 The 
observed attenuation of LTF after injury may therefore be due to apoE4-dependent 
decreases in 5-HT receptor expression on PMNs, or a result of alterations downstream of 
5-HT receptor activation in the signaling pathways that are necessary for the induction of 
LTF. 
Although the higher density of PNN in E4 females is not associated with a 
decrease in the amount of 5-HT at the level of the PMN after injury, the CSPG-
containing PNN could still play a role in abrogating respiratory motor plasticity. Further 
investigations are needed to determine whether CSPGs block ion flow in spared axons 




thoracic injury.453,454 Previous studies have shown that degradation of CSPGs leads to 
increased presence of 5-HT around PMNs, which is associated with recovery of breathing 
function. However, these studies did not address at the effect of CSPG upregulation or 
degradation on glutamatergic sprouting or regeneration.209,218,422 Therefore, alterations in 
glutamatergic innervation of PMNs could also contribute to the enhancement of 
diaphragmatic function demonstrated in these studies. Although E4 females displayed 
more 5-HT fibers than E3 females, further examination of glutamatergic axon 
regeneration and sprouting, as well as how enzymatic degradation of CSPGs alters this 
innervation, could provide insight into whether PNN upregulation contributes to a lack of 
respiratory motor plasticity in females expressing 4. 
The primary goal of this study was to investigate the role of genetic variability in 
determining an individual’s propensity for spinal plasticity and recovery of breathing 
function after SCI. Preclinical studies typically test therapeutic approaches in a 
homogenous group of animals, which does not represent the diversity found in the human 
population. As IH and other therapeutics enter clinical trials, their efficacy for treating a 
heterogeneous population is an important consideration. Overall, our findings that sex 
and APOE genotype modulate the response to therapeutic IH, along with the current 
dearth of successful treatment strategies for SCI, emphasizes the importance of advancing 






Figure 3.1 Magnitude of respiratory motor plasticity is not determined by 
APOE genotype alone.  
A. Timeline of intermittent hypoxia protocol. Green arrows represent time points at which 
peak amplitude was analyzed. B. Schematic of the neural circuitry that mediates 
breathing. Location of the left C2 hemisection is indicated by red X. C. Representative 
image of cresyl violet staining of the spinal cord at the C2 level after injury. D. 
Quantification of diaphragmatic amplitude over time during and after IH. There was no 
difference between genotypes in the change in amplitude over time (RM ANOVA 
p=0.741) E. Quantification of diaphragmatic amplitude during the first normoxic bout 







Figure 3.2 ApoE3 males demonstrate a trend of decreasing diaphragmatic 
activity in response to IH.  
A. Representative traces of diaphragmatic activity during the first normoxic bout and 40 
minutes after IH. B. representative traces from male mice that had no spontaneous 
recovery. C. Quantification of diaphragmatic activity over time during and after IH. 
Amplitude of diaphragmatic bursts is not significantly different between E3 and E4 
animals. D. Quantification of diaphragmatic activity during the first normoxic bout and 
40 minutes after IH (RM ANOVA E3/E3 t=0.03, E3/E4 norm t=-0.55, E3/E4 40 min t=-






Figure 3.3 ApoE4 females display significantly less diaphragmatic activity 
than E3 females after IH.  
A. representative traces of diaphragmatic activity during the first normoxic bout and 40 
minutes after IH.B. representative traces from an apoE4 female non-responder. C. 
Quantification of diaphragmatic activity over time during and after IH. Amplitude of 
diaphragmatic bursts are significantly greater in E3 females than in E4 at 40 minutes 
post-IH (RMANOVA t=1.01. D. Quantification of diaphragmatic activity during the first 
normoxic bout and 40 minutes after IH (RM ANOVA E3/E3 t=-0.32, E3/E4 normoxia 






Figure 3.4 E4 females have higher levels of PNN.   
A. Representative images of WFA staining at the C4 spinal cord level (DAPI is in red, 
WFA is in green). B. Higher magnification images show the PNN surrounding putative 
phrenic motor neurons. C. Quantification of WFA indicates that apoE4 mice express 
more WFA than E3 mice, although this trend is not statistically significant (Welch’s t-test 






Figure 3.5 E4 females have higher density of spinal 5-HT fibers.   
A. Representative images of stained 5-HT fibers in the C4 spinal cord level. Higher 
magnification shows individual 5-HT fibers in the area of the putative PMN. C. 
Significantly more serotonergic fibers are found ipsilateral to injury in apoE4 females 
(Student’s t-test p=0.0193).  D. 5-HT fibers contralateral to injury at the C4 level 
(Student’s t-test p=0.286). E. Ipsilateral 5-HT staining normalized to contralateral 





CHAPTER 4. INTERACTIONS OF SEX AND APOE GENOTYPE IN THE 
MODULATION OF RESPIRATORY MOTOR PLASTICITY 
4.1 Introduction 
Drawing breath is crucial for maintaining life. The respiratory system must be 
adaptable to changes in the environment or alterations in homeostatic signaling in order 
to preserve its optimal functioning at all times. The neural pathways that mediate 
breathing form complex and interconnected circuits throughout the brainstem and 
cervical spinal cord that regulate respiratory motor output in response to physiological 
signals from peripheral systems. This dynamic system changes throughout an organism’s 
life as metabolic demand is altered during exercise, sleep, stress, or more gradual 
processes like aging.455–457 When these experience-dependent changes in the neural 
control of breathing persist long after a stimulus is removed, they are considered a form 
of respiratory neuroplasticity.458  
Breathing is controlled by respiratory nuclei in the brainstem.459,460 The pre-
Bötzinger complex (pre-BötC), located bilaterally in the ventral medulla, is one such 
nucleus that performs the crucial function of rhythmogenesis for the respiratory phases.461 
Classically, rhythmogenesis was thought to depend solely pro-Bötc neurons. More 
recently, however, other centers of rhythmicity such as the parafacial nucleus have been 
identified in the brainstem.177,462 Neurons in the pre-BötC extend their axons across the 
midline to synchronize respiratory rhythm with the contralateral pre-Bötc.159,461,463 These 
neurons also communicate with other medullary respiratory nuclei including the rostral 
ventral respiratory group (rVRG).158 Glutamatergic premotor neurons of the rVRG 




phrenic motor neurons (PMN).415,464 Utilizing this circuitry, brainstem respiratory nuclei 
control inspiratory rhythms by determining the timing of inspiratory muscle contraction. 
Excitation of the PMN is additionally modulated by serotonergic projections descending 
from the caudal medullary raphe.465 
Adjustments in breathing activity are imperative to maintain tissue oxygenation 
and prevent hypercapnia. Therefore, the neural control of breathing must be sensitive and 
responsive to changes in O2 and CO2 levels. To this end, the brainstem has local 
chemosensation capacity. The retrotrapezoid  and parafacial nuclei sense changes in CO2 
and pH, which are communicated to the preBötC, inducing alterations in ventilation to 
increase pO2.
175,466 Brainstem nuclei also respond to feedback from peripheral 
chemoreceptors.170 Afferent signals from chemosensitive neurons in the carotid body are 
transmitted to the NTS, which communicates with the preBötC to influence breathing 
activity171,467 
Decreased environmental oxygen levels lead to the hypoxic ventilatory response 
(HVR), consisting of an initial increase in ventilation followed by short term potentiation 
of phrenic nerve activity once the hypoxic bout ends.430,468,469 In contrast, intermittent 
bouts of hypoxia can induce long term facilitation (LTF) through serotonin and BDNF-
dependent mechanisms.224,268 LTF is characterized by a prolonged increase in breathing 
motor output that endures long after cessation of hypoxia.387 The capability of 
intermittent hypoxia (IH) to induce LTF has been demonstrated in human subjects and 
numerous animal models.231,249,386,387 This well-characterized model of respiratory motor 
plasticity is a useful indicator for the capacity of the breathing circuitry to respond to the 




of the central nervous system (CNS), we sought to determine whether individuals’ 
propensity for breathing plasticity may be impacted by human genetic diversity. 
One gene of particular interest is apolipoprotein E (APOE), which is present in 
three isoforms in the human population: 2, 3, and 4. Previous studies of the APOE 
alleles, which encode the apoE protein, have indicated that the E4 isoform is associated 
with depressions in synaptic plasticity in neuronal cell culture and in the brain.326,331,337 
However, the influence of the distinct apoE isoforms on respiratory or spinal plasticity 
remains unexplored. Therefore, we utilized LTF, to investigate how APOE genotype 
impacts the propensity for plasticity in the neural circuitry that controls ventilation. We 
hypothesize that humanized mice expressing the human 4 allele will display a lower 
magnitude of LTF compared to other genotypes, indicating that genetic background 
predisposes individuals toward or against neural plasticity in the breathing circuitry.  
4.2 Methods 
This chapter of the Dissertation has been adapted from a manuscript submitted to 
Respiratory Physiology and Neurobiology for review. 
 
4.2.1 Animals 
All experiments were approved by the Institutional Animal Care and Use 
Committee of the University of Kentucky. Mice expressing human apoE isoforms under 
control of the mouse APOE promotor (targeted replacement mice) were backcrossed for 
at least 10 generations to the C57BL/6 background.398–400 Mice were group-housed on a 
twelve-hour light/dark cycle and fed normal chow diet ad libitum. Diaphragmatic EMG 




time C57BL/6 mice are considered mature adults.470 Since APOE alleles differentially 
influence CNS health during aging, young adults were utilized in this study to avoid these 
confounds.471–473   
 
4.2.2 Intermittent Hypoxia and Diaphragmatic Electromyography (EMG) 
Mice were anesthetized with isoflurane using the SomnoSuite Anesthesia System 
(Kent Scientific). A laparotomy was performed by cutting through the rectus abdominis, 
external oblique, and internal oblique muscles. Bipolar electrodes, connected to an 
amplifier and data acquisition system (CWE BMA-400 Four-channel Bioamplifier, CED 
1401 with Spike2 Data Analysis Computer Interface), were inserted into the dorsal region 
of the left hemidiaphragm, where they were secured using Vetbond. The laparotomy was 
also closed using Vetbond. 10 minutes of baseline breathing activity were recorded. The 
air input to the Somnosuite was then changed from room air (normoxia) to a premixed 
gas of 11% oxygen, 89% nitrogen gas (hypoxia) for 5 minutes, at which point it was 
switched back to room air for 5 minutes. This was repeated for 3 bouts of hypoxia 
separated by 5 minutes of normoxia. Diaphragmatic activity was recorded for 1 hour after 
the final hypoxic bout.  
To harvest tissue for immunohistochemistry, mice were perfused with 4% 
paraformaldehyde (PFA). The spinal column was isolated and placed in 4% PFA at 4C. 
After two days, tissue was removed from PFA and placed in a 30% sucrose solution at 
4C for cryoprotection until sectioning. 
To harvest fresh tissue for molecular analysis, mice were sacrificed through 




isolated and immediately placed on dry ice. The brainstem was also preserved on dry ice 
for future genotyping. All tissue samples were stored at -80C.  
 
4.2.3 Hypoxic ventilatory response assessment 
Mice were anesthetized with isoflurane and diaphragmatic EMGs were recorded 
as described in section 2.2. Recordings were performed for 1 hour and 40 minutes to 
serve as a time control for mice that underwent IH with concurrent EMG recordings. At 
the end of that time, mice were exposed to a 10 minute bout of hypoxia. Mice were then 
returned to normoxic conditions and overdosed with isoflurane. 
 
4.2.4 Sectioning and Staining  
Tissue was mounted and frozen in Tissue Plus O.C.T. Compound (Fisher 
Healthcare) and cut at a thickness of 20m on a cryostat (Leica). Serial sections from the 
level of the PMN (C3-C6) were collected on gelatin-coated slides then placed  on a slide 
warmer at 32C to prevent section from washing away during IHC. For serotonin (5-HT) 
staining, frozen sections were thawed to room temperature, rinsed with 1x PBS, and 
blocked in a solution of 5% normal goat serum, 0.1% bovine serum albumin, and 0.1% 
TritonX-100 dissolved in PBS. Slides were incubated in 5-HT primary antibody diluted 
1:10,000 (rabbit, ImmunoStar Cat #20080) then goat anti-rabbit AlexaFluor488 
secondary antibody (1:500, Life Technologies Cat #A11034). Stained slides were 
mounted with ProLong Gold mountant with DAPI (Invitrogen Cat #P36931). For WFA 
(Wisteria Floribunda Lectin) staining, frozen sections were thawed to room temperature, 




then incubated in WFA primary antibody conjugated to Fluorescein at a dilution of 1:400 
(Vector Labs Cat #FL-1351). Stained slides were mounted in ProLong Gold with DAPI.  
 
4.2.5 Trace Analysis 
After recording, raw diaphragmatic EMG was rectified and integrated using 
Spike2 software. Analysis was performed at twelve time points: twice during baseline 
recording, once during each hypoxic and normoxic bout, and at 10, 20, 30, and 40 
minutes after the final hypoxic period (Fig. 4.1 A). For each time point, peak amplitude 
was averaged over a 30 second period. Amplitude of diaphragmatic bursts at each time 
point were normalized to that animal’s pre-hypoxia baseline amplitude. Frequency of 
diaphragmatic bursts, indicative of breaths, was also quantified over a 30 second period 
at each time point. 
To quantify diaphragmatic activity during hypoxia as a proxy for assessing HVR, 
analysis was performed at 0, 5, and 10 minute time points during the hypoxic bout (Supp 
Fig. 1 A). Amplitude was normalized to the animal’s pre-hypoxia baseline amplitude.  
 
4.2.6 Imaging and image quantification 
Staining for WFA was imaged on a Keyence BZ-X810 fluorescence microscope 
for quantification. Cresyl violet stained sections were imaged using brightfield 
illumination at 2x. Sections stained for WFA were imaged at 10x using the 
monochromatic camera with high resolution (0.75488m/pixel) for quantification. 
Additional images for publication were acquired on a Nikon Eclipse Ti series inverted 




stained for 5-HT were imaged on the Nikon at 20x. Images of 5-HT staining for 
publication were taken at 40x in the region of the PMN. All imaging and quantification 
was performed on the ventral horn of the left side of the cord, ipsilateral to the injury. 
WFA labeling was quantified using the HALO image analysis platform (Indica 
Labs). We developed and optimized an algorithm on the Area Quantification v1.0 to 
capture positive staining for WFA while omitting any nonspecific fluorescence. A region 
of interest (ROI) was drawn around the left ventral horn of sections at the level of C4. 
The quantification algorithm was applied to the ROI of each section. The area of staining 
was then normalized to the total area of the ROI. Three tissue sections at level C4 were 
analyzed for each animal. 5-HT labeling was also quantified with HALO. A region of 
interest was drawn around the left ventral horn. Serotonergic fibers withing the ROI were 
traced using the embedded annotation tool. The total length of fibers was then normalized 
to the area of the ROA.  
 
4.2.7 ELISA 
Spinal cord tissue was homogenized in protein lysis solution (10ml of 1x RIPA 
with 1 tablet of Roche protease inhibitor) buffer using a Tissuemiser Homogenizer 
(Fisher Scientific). The supernatant was isolated and diluted 1:24 in 1x PBS for a BCA 
assay (Pierce, cat #23225). Once protein concentration was determined, samples were 
diluted 1:4 and BDNF protein was quantified using the Meso Scale Discovery BDNF 
Uplex Assay (cat # K1526WK-1). The Meso Scale assay was run by the Biomarker 






4.2.8 Experimental Design and Statistical Analyses 
Sample sizes for mice receiving diaphragmatic EMG recordings were calculated 
based on preliminary data from 10 hemisected mice representing all three genotypes 
using Cohen’s D to measure effect size (same analysis as Chapter 3.2.6). Group sizes for 
each sex and genotype are found in Table 1. Tissue from a subset of animals was 
perfused with PFA and spinal cord tissue was harvested from these animals for IHC and 
quantification of WFA and serotonergic sprouting (n=3 for each genotype) 
For statistical analysis of EMG traces, repeated measures (RM)-ANOVA was 
used to account for within-subject correlation given repeated measurements over time. 
Stratified RMANOVA analyses were performed on male and female traces. For a priori 
pairwaise comparisons, results were considered statistically significant if t1.96. 
Student’s t-test was used to analyze 5-HT fiber staining on spinal cord tissue. Welch’s t-
test for unequal variances was used to analyze staining of WFA. Results were considered 
statistically significant if p < 0.05. 
To analyze BDNF ELISA results, the amount of BDNF was calculated in pg/mg 
for each animal. One-way ANOVAs were performed to compare genotypes in female 
mice (2 n=9, 3 n=8, 4 n=8) and male mice (2 n=7, 3 n=7, 4 n=6). Results were 





Table 4.1 Data for sample size calculation 
 
Male  Female 
E2 n=8 n=10 
E3 n=8 n=10 




4.3.1 ApoE isoforms and respiratory motor plasticity 
Diaphragmatic EMG recordings were performed in male and female mice at 3.5-4 
months of age (2 n=18, 3 n=18, 4 n=17). Mice were exposed to three bouts of 
intermittent hypoxia (11% O2) while concurrent diaphragmatic EMGs were recorded 
from the left hemidiaphragm. Fig. 4.1 A illustrates the IH protocol utilized in these 
experiments, along with the time points at which diaphragmatic burst amplitude and 
frequency were quantified. Fig. 4.1 B highlights some of the neural pathways in the 
medulla and spinal cord that mediate respiratory motor control and rhythmicity. Plasticity 
in this neural circuitry can be enhanced by IH, leading to augmentation of diaphragmatic 
activity that is typically observed as an increase in burst amplitude.224 However, instead 
of the expected augmentation of diaphragmatic output, mice of all genotypes displayed a 
decrease in burst amplitude over time after IH (Fig. 4.1 C., p<0.0001). The magnitude of 
this decrease did not differ between genotypes (p=0.955). Since mice of all genotypes 
demonstrated an immediate deterioration of diaphragmatic burst amplitude in response to 
the first bout of hypoxia, we compared amplitudes during the first 5-minute bout of 




comparison was to determine whether there was an IH-induced increase in breathing 
output after the initial decline in amplitude. There was no difference in burst amplitude 
between these time points within or between genotypes, as shown in Fig. 4.1 D (p=0.955) 
 
4.3.2 Sex effects on respiratory motor plasticity in APOE targeted replacement mice 
EMG data was then divided according to sex to investigate whether there were 
sex-dependent influences on how apoE isoforms influence breathing. Fig. 4.2 A. shows 
representative traces from male mice expressing 2, 3, or 4 (n=8 for each genotype) 
during the first normoxic bout and forty minutes after IH. As seen in these EMG traces, 
breathing frequency declines over time in all three genotypes, which is quantified in Fig. 
4.2 B (p=0.0013). The magnitude of this decrease does not differ between genotypes 
(p=0.210). There was also no statistically significant difference in the amplitude of 
diaphragmatic activity during or after IH when comparing genotypes (Fig. 4.2 C). 
However within the male apoE4 mice, there was a significant decrease in burst amplitude 
over time (Fig. 4.2 D, t=0.16) while E2 and E3 males demonstrated no change in 
amplitude (t=0.12 and t=0.29, respectively). 
Representative traces in Fig. 4.3 A demonstrate how breathing in female APOE 
targeted replacement mice changes in response to IH. Similar to male mice, females also 
displayed a decrease in breathing frequency over time (p<0.0001, 2 n=10, 3 n=10, 4 
n=9), but no difference between genotypes emerged when measuring the degree of this 
decline (Fig. 4.3 B, p=0.429). Quantification of EMG amplitude revealed that females 
expressing 3 experience an attenuation of breathing activity after IH treatment. By 40 




compared to those expressing 2 (Fig. 4.3 A,C,D, t=2.20), indicative of maladaptive 
plasticity in these animals.  
In response to hypoxic conditions, rodents increase breathing ventilatory 
frequency and volume in order to compensate for decreased levels of arterial O2 detected 
by peripheral chemoreceptors. This phenomenon is known as the hypoxic ventilatory 
response (HVR, previously described by Pamenter and Powell, 2016). In our APOE 
humanized mice, there was a consistent decrease in diaphragmatic activity in response to 
the first hypoxic bout during IH, instead of the expected increase. Therefore, we exposed 
small cohorts (n=2-3) of male and female mice to a single 10-minute bout of hypoxia 
(11% O2) and quantified their diaphragmatic response to determine whether this hypoxia-
induced decrease in respiratory activity is apoE isoform-dependent. Males displayed no 
change in frequency or amplitude of diaphragmatic output. Females likewise did not 
demonstrate a change in amplitude in response to hypoxia. However, E4 females did 
display a trend of diminishing frequency of breaths during hypoxia (Fig. 4.4 B-E). 
 
4.3.3 The presence of the perineuronal net and respiratory motor plasticity 
The perineuronal net (PNN),  is a specialized extracellular matrix that surrounds 
CNS neurons that contains chondroitin sulfate proteoglycans (CSPGs). High densities of 
these CSPG molecules has previously been shown to interfere with neuronal signaling 
453,454. Therefore, we quantified the density of the PNN around the putative phrenic motor 
neurons in the ventral horn of the C4 spinal cord (Fig. 4.5 A,B) in female mice to 
determine whether the differences between genotypes observed in diaphragmatic EMG 




staining in APOE targeted replacement mice indicated that there was no difference 
between genotypes in the amount of PNN detected (Fig. 4.5 C, 1-way ANOVA 
p=0.5853, n=3 for each genotype).  
 
4.3.4 Serotonin and BDNF levels in mice expressing human APOE 
LTF is a serotonin (5-HT)-dependent form of plasticity.224 To assess whether the 
divergence of respiratory responses to IH observed in females was due to apoE-
dependent alterations in the amount of 5-HT present around PMNs, we quantified 
staining of serotonergic fibers in the C4 ventral horns (Fig. 4.6 A-B). There was no 
significant difference between genotypes when comparing the volume of 5-HT+ fibers in 
the vicinity of putative PMN (Fig. 4.6 C, p=0.182, n=3 for each genotype). However, a 
trend emerged of E3 females exhibiting fewer 5-HT fibers than females expressing the 2 
or 4 alleles. Due to low n’s in this experiment, future work will further investigate 
whether this trend persists when group sizes are increased. 
Following IH, increased activation of 5-HT receptors on phrenic motor neurons 
leads to downstream production of new BDNF, a molecule which is both necessary and 
sufficient to induce LTF.268 Although 5-HT levels around putative PMNs were not 
significantly different between genotypes, downstream signaling pathways could still be 
disrupted in E4 males and E3 females, leading to the observed maladaptive responses to 
IH. Therefore, we quantified downstream production of BDNF. However, measurement 
of BDNF protein by ELISA in the region of the phrenic motor nucleus also revealed no 
difference between genotypes in males (Fig. 4.7 A, p=0.216, 2 n=9, 3 n=8, 4 n=8) or 





The body’s ability to alter breathing in response to stimuli is imperative to 
maintain proper tissue oxygenation in different environments or metabolic states. This 
plasticity in the neural circuitry that mediates breathing is therefore critical in health and 
disease. The current study represents the first investigation into how the three alleles of 
the APOE gene could influence individuals’ capacity for this plasticity in intact animals. 
Understanding how sex and genetic differences alter respiratory control in an intact 
system will facilitate the development of approaches to enhance the ventilatory response 
to respiratory challenges and disease in the diverse human population. The 2, 3, and 4 
alleles have previously been shown to differentially alter synaptic integrity and plasticity 
in the brain, although the impact on spinally-mediated plasticity has hitherto remained a 
mystery.407,474,475 Indeed, our results support the hypothesis that APOE genotype 
predisposes individuals towards or against respiratory motor plasticity, an effect which is 
further dependent upon sex. 
 
4.4.1 Respiratory motor plasticity in APOE targeted replacement mice 
A vast body of literature has investigated and described the respiratory response 
to intermittent hypoxia in rodents. What has emerged from this work is a well-described 
model of respiratory motor plasticity known as LTF, which is characterized by a 
prolonged increase in breathing output.219,227 Although the induction of ventilatory LTF 
through exposure to IH is also viable in human populations, the influence of human 
genetic factors on the development of this plasticity remains underexplored.142,249 By 




activity, we were able to demonstrate that there were no significant differences between 
genotypes in the respiratory response to IH when sex was not considered as a biological 
variable. 
The majority of previous studies examining IH-induced changes in breathing have 
been performed in rats, leading to optimized IH protocols that have determined how 
severity and duration of hypoxia changes the breathing response.226 In contrast, few 
studies have addressed the mouse response to IH. The limited existing literature describes 
IH protocols and outcome measures that vary greatly between labs.231–234 Due to the 
disparities in both approach and evaluation, it is unclear how the manifestation of LTF 
differs in mice and rats, as well as how that manifestation might further diverge as a 
result of which IH protocol is used.  
An important consideration when evaluating LTF expression and the efficacy of 
IH is that LTF can be induced through two conflicting signaling mechanisms, known as 
the Q and S pathways. While the Q pathway is activated through 5-HT2A or 5-HT2B 
receptors in response to moderate IH, the S pathway is activated through adenosine 2A or 
5-HT7 receptors after severe IH.
226,476–478 The IH protocol that our mice experienced 
corresponded with moderate IH protocols used in rats. However, while the differences in 
these pathways and the crosstalk between them has been well-documented in rats, these 
distinctions may not be comparable in mice. Therefore, further studies are needed to 
determine whether our protocol is activating the Q or S pathway. If it is activating both 
pathways, evidence from Hoffman and Mitchell (2013), Devinney et al. (2016), and 




This could explain why mice of all genotypes did not demonstrate the expected increases 
in breathing after IH treatment that would be indicative of LTF. 
 
4.4.2 Sex differences in the influence of APOE on respiratory motor plasticity 
The importance of considering sex as a biological variable in biomedical research 
has been emphasized in recent years. Regarding breathing, sex determines lung volume, 
airway size, and the respiratory response to exercise.481,482 Indeed, the sex hormone 
progesterone acts as a breathing stimulant and has been used to treat breathing disorders 
such as obstructive sleep apnea and chronic respiratory insufficiency.374,483,484 Although 
sex hormones do not appear to alter pre-Bötc function, as demonstrated by unaltered 
respiratory frequency in ganodectomized animals371, other components of the neural 
control of breathing are influenced by estrogen and progesterone. The serotonergic raphe 
nuclei, which communicate with respiratory nuclei both in the brainstem and spinal cord, 
express estrogen and progestin receptors. Estrogen signaling in the raphe enhances 5-HT 
neurotransmission, suggesting that high estrogen levels in females could augment IH-
induced plasticity.485 
Considering the impact of sex on the neural control of breathing and the 
importance of 5-HT signaling in inducing LTF, we divided our APOE targeted 
replacement mice into males and females for individual analysis. As in the combined 
analysis, EMG recordings in males demonstrated no statistically significant genotype-
dependent divergence in the amplitude of diaphragmatic bursting at any analyzed 




burst amplitude over time after IH compared to baseline, indicating that these males may 
have a maladaptive response to hypoxia-induced increases in respiratory drive.  
By exposing young adult male rats to IH, Zabka et al. (2006) previously provided 
evidence that male rodents increase breathing motor output in response to IH. The 
contradictory attenuation of breathing that we observed in E4 males could be due to 
hypoxia-induced changes in metabolism that are exacerbated by sex and APOE genotype. 
In small rodents, hypoxia induces a decrease in metabolism in order to decrease oxygen 
consumption.441 This hypoxic hypometabolism prevents the need for increased 
ventilation in hypoxic conditions, which could explain the lack breathing augmentation in 
our animals. To control for the potential of  metabolism to impact the manifestation of 
LTF, artificial ventilation with pCO2 and temperature sampling would be necessary to 
ensure that metabolism is being held constant for the duration of IH exposure. However, 
due to the low blood volume of mice, pCO2 sampling throughout EMG recordings was 
not possible. Previous work has shown that APOE genotype alters glucose flux through 
cerebral metabolic pathways of humans and targeted replacement mice, with 4 carriers 
displaying hypometabolism in various brain regions, an effect which is aggravated in 
males.486–488 Less is known about how apoE isoforms differentially impact metabolism in 
the spinal cord and the neural circuitry that mediates breathing. Metabolic impairments in 
E4 males could explain why they displayed more significant decreases in breathing 
activity. 
In contrast to male mice, female diaphragmatic burst amplitude after IH differed 
significantly between genotypes. Compared to 2 females, those expressing 3 have 




hypothesis that apoE4 would be the isoform that proved to be detrimental to spinal and 
respiratory plasticity. Previous studies of the APOE targeted replacement mouse CNS 
have focused on the brain due to the implication of the 4 allele in contributing to the 
development of Alzheimer’s Disease (AD). A vast body of literature has investigated the 
influences of the APOE alleles on neural plasticity and metabolism, especially in the 
areas of the brain that are most severely impacted by AD. In the hippocampus and 
entorhinal cortex, E4 carriers exhibit reduced dendritic spine density and synaptic 
plasticity, leading to learning and memory impairments.331,489–492 Little is known about 
how the APOE alleles may influence neural plasticity in the spinal cord. However, the 
E3-induced deficits in respiratory motor plasticity found in females was unexpected. To 
our knowledge, E3 has never been shown to have inhibitory effects on plasticity. 
Interestingly, modulation of plasticity by apoE is age and region-dependent in the brain, 
as evidenced by apoE4’s ability to enhance hippocampal synaptic plasticity in young 
mice, an effect that declines with aging.447,448 Therefore, influences of the 3 allele could 
be equally as varied and dependent upon age, region of the CNS, and sex. 
The diaphragmatic response to hypoxia, representative of HVR, in female mice 
also exhibited genotype-dependent deviations. Although there was no significant 
difference in diaphragmatic burst amplitude, the breath frequency of E4 females did 
display a sharp decline after five minutes of hypoxic exposure, which persisted until the 
end of the ten-minute bout. These findings indicate that there may be genotype influences 
on pre-Bötc rhythmogenesis. Although this decline in breathing frequency was exhibited 
by females expressing 4 after a single hypoxic bout, repeated hypoxic episodes lead to a 




how APOE genotype influences plasticity in the neural control of breathing at different 
neurological levels. While alterations in frequency are brainstem-mediated, differences in 
amplitude after IH could result from effects on brainstem respiratory nuclei or on PMNs 
themselves.430 
 
4.4.3 APOE-dependent density of the PNN and the neural control of breathing 
There are many possible mechanisms by which the variant isoforms of apoE may 
alter the neural control of breathing and impact the respiratory system’s response to the 
environment. One potential route is through changing the density of the perineuronal net 
(PNN). The PNN is a specialized network of CSPG-containing extracellular matrix that 
appears during development to surround neurons and modulate synaptic plasticity in the 
CNS (reviewed by Bosiacki et al., 2019; Wang and Fawcett, 2012). Development of the 
PNN is dependent upon neuronal activity, with its appearance beginning as periods of 
synaptogenesis and myelination of the nervous system are closing.495–497 
While the CSPG-containing PNN has important functions in maintaining synaptic 
homeostasis, it can also impede axonal ion transport and conduction of action 
potentials.453,454 Postsynaptically, PNN molecules can prevent lateral diffusion of AMPA 
receptors.498 Therefore, alterations in signaling or synaptic plasticity in the breathing 
circuitry could be a result of apoE-dependent variations in the density of the PNN, which 
leads to changes in the efficiency of neural communication. In female mice that  
demonstrated significant genotype-dependent differences in the respiratory response to 
IH, staining of the PNN around putative PMNs demonstrated no difference in PNN 




the cause of respiratory differences between APOE genotypes, further studies are needed 
to determine whether there could be apoE-dependent alterations in the molecular 
composition of the PNN. Conejero-Goldberg et al. (2015) previously established that 
expression of a specific CSPG known as brevican, which is implicated in brain plasticity, 
varies between APOE genotypes. This suggests that distribution of various CSPGs 
subtypes within the PNN could also be a source of genotype-induced modifications in the 
neural circuitry that mediates breathing.  
 
4.4.4 LTF signaling pathways in APOE targeted replacement mice 
LTF is a serotonin-dependent form of plasticity.224 Activation of 5-HT receptors 
leads to downstream production of new BDNF in PMNs.268,499 In targeted replacement 
mice, APOE genotype did not alter the levels of 5-HT or BDNF observed in the area of 
the phrenic motor nucleus, suggesting that differences in the breathing response to IH are 
not dependent on the expression of these molecules. While the disparities observed in the 
neuroplastic response to IH may not be due to apoE’s influence on presence of BDNF or 
5-HT, there could also be downstream genotype-dependent deficits in the signaling 
pathways that lead to the manifestation of LTF. Newly synthesized BDNF binds to the 
TrkB (tropomyosin receptor kinase B) receptor, which is ultimately thought to induce 
phosphorylation of glutamate receptor subunits in PMNs.380,500 The manner in which 
isoforms of apoE may influence this downstream signaling cascade currently remains a 
subject of ongoing investigation. However, E4 has previously been shown to mitigate 
glutamate receptor phosphorylation and membrane localization in cortical neurons326, an 




ApoE in the CNS is primarily synthesized and lipidated by astrocytes and 
isoforms of apoE differentially modulate astrocytic cell functions such as phagocytosis, 
glucose metabolism, and lipid homeostasis.303,324,395,501,502 In the brainstem, astrocytes 
perform important oxygen sensing functions that regulate the neural control of breathing 
(reviewed by Gourine and Funk, 2017). Even in the absence of peripheral 
chemosensation, brainstem astrocytes sense local hypoxia when mitochondrial O2 
consumption decreases.504 Inhibition of mitochondrial respiration stimulates an influx of 
Ca2+, inducing vesicular release of ATP. In the preBötC, this astrocytic ATP release 
activates the hypoxic ventilatory response in order to increase breathing activity.505 
However, the impact of APOE genotype on this central O2 sensing mechanism is 
unknown. Intriguingly, apoE4 is associated with impaired mitochondrial respiration and 
disruptions in Ca2+ homeostasis, suggesting that it could also undermine the role of 
central chemosensation in activating the respiratory response to hypoxia.328,486,506 
Although further studies are needed to determine how brainstem astrocytes are affected in 
our model, this could contribute to the lack of hypoxia-induced breathing augmentation 
observed in APOE targeted replacement mice.  
 
4.4.5 Conclusions 
Breathing function must be maintained throughout life to ensure that tissue 
oxygenation does not decline to deleterious levels. As people encounter hosts of diverse 
environments during their lifespan, their respiratory systems need to be able to quickly 
adapt to varying amounts of atmospheric oxygen, as well as oscillating activity levels. 




patters in response to chemoreceptor feedback. However, little is known about how 
genetic diversity and sex interact to determine individuals’ ability to initiate this 
respiratory motor plasticity. Our data demonstrates that both sex and APOE genotype 
dictate the respiratory response to hypoxia, thereby establishing that a subset of the 
population may not have beneficial responses to respiratory challenge. This data could 
have important repercussions for individuals who are often faced with hypoxic challenge, 
including athletes, people traveling to high altitude areas, or people who live with 
conditions that regularly expose them to hypoxic challenge including sleep apnea, 
chronic obstructive pulmonary disease (COPD), high level cervical spinal cord injuries, 
and many others. More studies are needed to further investigate the mechanism behind 
these APOE-depended effects, thereby paving the way to discover approaches to combat 






Figure 4.1 Magnitude of respiratory motor plasticity is not determined by 
APOE genotype.  
A. Schematic of intermittent hypoxia protocol. Green arrows represent time point at 
which peak amplitude was analyzed. B. Schematic of the neural circuitry that mediates 
breathing. C. Amplitude of diaphragmatic bursts over time during and after IH). D. 
Comparison of burst amplitude during the first normoxic bout and 40 minutes after IH. 





Figure 4.2 IH induces a decline in breathing activity in males expressing the 
human APOE 4 allele.  
A. Representative diaphragmatic EMG traces from E2, E3, and E4 males during the first 
normoxic bout and 40 minutes after IH. B. Breath frequency in male humanized mice 
decreases over time (p=0.0013), regardless of APOE genotype (p=0.210). C,D. 
Quantification of diaphragmatic burst amplitude during and after IH. Amplitude 
significantly decreases over time after IH in E4 males.  (RMANOVA for a priori pairwise 
comparisons 2x2: t=0.12, 3x3: t=-0.29, 4x4: t=2.00, 2x3 normoxia t=-.052, 
2x4 normoxia t=-0.68, 3x4 normoxia: t=-0.16, 2x3 40 min: t=-0.81, 2x4 40 min: 






Figure 4.3 Amplitude of diaphragmatic activity decreases in response to IH in 
apoE3 females.  
A. Representative traces from APOE targeted replacement mice during the first normoxic 
bout and 40 minutes after IH. B. Breathing frequency in female mice declines over time 
after IH (p <0 .001). However, there is no difference between genotypes (p=0.429). C,D. 
Quantification of diaphragmatic burst amplitude over time during and after IH. E3 
females displayed significantly decreased amplitude at 40 minutes post IH compared to 
E2 females (RMANOVA with a priori pairwise comparisons 2x2: t=-1.05, 3x3: t=-
1.15, 4x4: t=-0.39, 2x3 normoxia t=0.79, 2x4 normoxia t=-0,06, 3x4 normoxia: 






Figure 4.4 Hypoxic ventilatory response does not differ according to APOE 
genotype 
A, C.  Quantification of diaphragmatic burst amplitude (A, RMANOVA p=0.2349) and 
frequency (C, RMANOVE p=0.4756)  in male mice (n=3 for each genotype). There were 
no statistically significant differences between genotypes. B, D. Quantification of the 
HVR response in female mice. No significant difference appears to emerge in the 
diaphragmatic burst amplitude (B). However, the frequency exhibits a decline by 5 
minutes that persists at 10 minutes. No statistics were performed for female mice due to 






Figure 4.5 Hypoxic ventilatory response does not differ according to APOE 
genotype 
A. Representative images of the spinal cord at level C4 stained for WFA, a marker of the 
PNN (green), and DAPI (blue). B. Higher magnification images of WFA staining. C. 







Figure 4.6 APOE genotype-dependent influences on 5-HT innervation of 
PMN.  
A. Representative images of the spinal cord at the C4 level stained for 5-HT (green) and 
DAPI (blue). B. Higher magnification images of 5-HT staining.  C. Quantification of 5-







Figure 4.7 IH-induced BDNF protein synthesis is not altered according to 
APOE genotype.  
Quantification of BDNF protein levels in APOE targeted replacement male (A. 1-way 






CHAPTER 5. DISCUSSION 
5.1 APOE genotype and respiratory motor plasticity 
 Because survival is dependent upon breathing function, the neural control of 
breathing must be able to adapt and maintain oxygen homeostasis in response to changes 
in the external environment or fluctuations in activity level and O2 consumption. 
Although some of these ventilatory modifications endure only as long as the stimulus is 
present, others last long after the stimulus is removed. These long-lasting changes, 
comparable to a sort of “memory”, are collectively known as respiratory motor 
plasticity.507 These forms of plasticity can manifest naturally over time, as observed 
throughout development, or in response to injury or disease.420,508,509 Alternatively, 
respiratory motor plasticity can be induced through a variety of experimental or 
therapeutic approaches, many of which rely on a mechanism of increased 5-HT signaling 
in the spinal cord.224,510,511 While respiratory plasticity is important for maintaining O2 
homeostasis in healthy individuals, its potential to compensate for or even restore lost 
breathing function has even greater implications for people whose breathing circuitry has 
been damaged. Therefore, it is crucial that we understand how factors in the human 
population, such as sex, genetic make-up, and age, may positively or negatively impact 
individuals’ ability to express this plasticity. 
 
5.1.1 Respiratory Response to IH in the Presence of Human ApoE 
 The human population consists of individuals who are genetically dissimilar and 




plasticity. Therefore, to investigate the role of genotype in modulating the propensity for 
plasticity, we examined the impact of human apolipoprotein E (apoE) isoforms on a well-
characterized model of respiratory motor plasticity. Although polymorphisms in a variety 
of human genes could alter spinal plasticity, a few of which were discussed in Chapter 
1.3, the three alleles of the APOE gene were of particular interest due to the vast body of 
literature describing their influence on brain plasticity in health and disease, which 
starkly contrasts with the lack of knowledge regarding their impact in the spinal cord. 
Despite the relative paucity of information on apoE’s role in spinal plasticity, previous 
work has shown that individuals who have experienced a spinal cord injury (SCI) 
demonstrate less motor recovery when at least one 4 allele is present.348,349 This suggests 
that APOE genotype does influence the plasticity of spinal circuits after injury. The 
current work aimed to determine if this effect was also present in the neural control of 
breathing and whether it was a result of spinal cord insult or if it could be observed in the 
intact state as well. 
 As a model of respiratory motor plasticity, we utilized long term facilitation 
(LTF), which is characterized by a measurable and prolonged increase in breathing motor 
output.224,507 LTF was first discovered as a response to repeated stimulation of the carotid 
sinus nerve.386 Subsequently, numerous studies in rats have investigated the signaling 
mechanism in phrenic motor neurons (PMNs) that leads to the augmentation of breathing 
activity seen during LTF, finding that it could also be induced through exposure to 
intermittent hypoxia (IH) or episodic intrathecal 5-HT dosing.224,268,382,387 By applying the 
episodic 5-HT dosing protocol described by MacFarlane and Mitchell (2009)382 to rats 




respiratory response to IH was not altered by the variant forms of apoE in spinally intact 
femaless. However, this lack of observable difference could have been due to insufficient 
sensitivity of diaphragmatic EMGs. It therefore did not rule out the possibility of apoE 
isoform-dependent influences at the synaptic level. Quantification of synaptic glutamate 
receptors, which are necessary for the induction of LTF384, showed no difference between 
E3 and E4 animals. However, rats treated with E3 demonstrated a slight increase in 
synaptic AMPA receptors in response to episodic 5-HT while E4 animals did not. 
Although the difference in synaptic receptor levels did not reach significance, this may 
indicate that human E4 protein diminishes the potential for inducing synaptic plasticity in 
response to stimuli.  
To determine whether isoform-dependent influences on spinal plasticity would be 
altered by SCI, these experiments were replicated in animals that undergone a C2 
hemisection. The majority of SCIs occur at the cervical level, which contains axons from 
brainstem respiratory nuclei, as well as PMNs themselves.464 Damage these bulbospinal 
fibers can disrupt breathing function, leading to diaphragm paralysis, ventilator 
dependence, and increased risk of life-threatening respiratory infections.178,180 However, 
in a rat C2 hemisection model of SCI, LTF is capable of restoring breathing function to 
the ipsilateral paralyzed hemidiaphragm.139,247 Following SCI in our animals, a trend 
emerged in which E3-treated rats demonstrated the expected 5-HT-induced augmentation 
of breathing activity while those receiving E4 did not. This trend did not reach 
significance, possibly due to small group sizes or inadequate sensitivity of diaphragmatic 
EMGs. Perhaps more insightful were the changes observed at the synaptic level. Episodic 




localized to PMNs in spinal cords that had been treated with human apoE4. Since 
signaling through NMDA receptors is necessary for LTF induction, this synaptic 
weakening could lead to a deficits in spinal plasticity and functional recovery after SCI in 
individuals that express the 4 allele.385 
 
5.1.2 Interactions of Sex and APOE Genotype in Modulating Respiratory Plasticity  
Initial studies utilizing rats treated with exogenous human apoE protein were 
valuable due to the amount of available literature describing the induction and 
manifestation of LTF in that model, which simplified experimental design and the 
interpretation of results. However, APOE targeted replacement mice that endogenously 
express the human apoE isoforms at physiological levels provide a more clinically 
relevant model. Therefore, subsequent studies examined allele-dependent influences on 
the propensity for LTF in humanized APOE mice. To explore the mechanism behind the 
lack of synaptic strengthening demonstrated by apoE4-treated rats, we also quantified 
signaling molecules that are required for LTF upstream of glutamate receptor trafficking 
in the mouse model. 
 The few studies that have characterized LTF in mice have induced LTF through 
exposure to IH instead of the episodic 5-HT dosing previously described in rats.231–234 
Therefore, we utilized IH as a means of inducing LTF in our humanized mice. 
Comparison of diaphragmatic EMG activity in hemisected APOE mice that 
homozygously express the 3 or 4 allele showed no allele-dependent differences in the 
respiratory response to IH. However, because sex is an important biological variable that 




breathing function, APOE  allele effects, and individuals’ response to therapeutics, we 
also independently analyzed data from males and females.355,358,362,442,512 There was no 
significant difference in diaphragmatic activity between E3 and E4 males, although IH 
appeared to decrease burst amplitude in those expressing 3. This data contradicts the 
trend observed in the brain, where the 4 allele is typically associated with attenuated 
plastic responses. This indicates that allele-dependent outcomes could be region-specific 
in the CNS, further emphasizing the need for deeper understanding of the influence of the 
unique apoE isoforms in the spinal cord. In contrast to the detrimental impact of 3 
observed in injured males, it was the 4 allele that correlated with a significant decline in 
diaphragmatic burst amplitude in females. These results are in alignment with previous 
studies in the Alzheimer’s literature reporting that detrimental effects of apoE4 are 
aggravated in females.336,442  
LTF is a serotonin-dependent form of plasticity.224 Manifestation of LTF after 
SCI is dependent upon the sprouting of 5-HT fibers in the spinal cord, suggesting that 
barriers to sprouting or regeneration would limit the capacity for respiratory motor 
plasticity.247 One notable barrier to regeneration and sprouting is the presence of CSPG 
(chondroitin sulfate proteoglycan) molecules. The secretion of these molecules is 
upregulated in response to SCI, although prior to the current study, it remained unknown 
whether the magnitude of this upregulated is modulated by human APOE alleles.99,409,422 
Despite increased levels of CSPGs located around the PMNs of E4 females, this did not 
correspond to a deficiency in 5-HT in the same region. Indeed, 5-HT levels were 
significantly increased in E4 animals, compared to those expressing the 3 allele. Since 




also demonstrate elevated 5-HT levels in the intact state, this may be the result of a 
compensatory mechanism that maintains PMN excitability in the presence of apoE4, 
which is associated with loss of synaptic integrity and impaired excitatory synaptic 
signaling.209,218,407,422,513 Although the availability of 5-HT in the phrenic motor nucleus 
may not cause the abatement of respiratory plasticity in E4 females, further studies are 
needed to determine whether 5-HT receptor expression and synaptic localization are 
altered by apoE4. 
 Activation of the chemosensitive carotid bodies during a single bout of hypoxia 
stimulates the hypoxic ventilatory response (HVR), characterized by a transient increase 
in respiratory output.430 Interestingly, mice utilized in the current study displayed a 
decrease in breathing activity in response to a single 10 minute bout of hypoxia, as well 
as during the first 5 minute hypoxic bout during IH. Intrigued by this unexpected result, 
as well as the lack of IH-induced ventilatory augmentation that we observed in uninjured 
apoE-treated rats, we next investigated the respiratory response to IH in spinally intact 
APOE mice. Similar to hemisected mice, there was no difference between genotypes 
when males and females were grouped together. However, upon separating the sexes for 
further analysis, 4 males and 3 females displayed significant IH-induced reductions in 
breathing activity, opposite of the trends observed after IH in injured mice. Quantification 
of CSPGs and 5-HT in intact mice revealed that E4 was again associated with higher 
levels of both molecules when compared to E3, although this did not reach significance. 
As part of the signaling cascade that leads to LTF, 5-HT signaling stimulates synthesis of 
new BDNF in PMNs, which is necessary for IH-induced augmentation of ventilation.268 




phrenic motor nucleus, which revealed no genotype-dependent differences, indicating 
that apoE isoform-dependent influences on LTF signaling occur downstream of BDNF 
synthesis. 
5.1.3 Significance of Findings 
 Together, results from our studies in two rodent species reveal that both sex and 
APOE  genotype modulate spinal and respiratory motor plasticity. While no APOE 
genotype-dependent differences are evident when males and females are grouped for 
analysis, the 3 and 4 allele are each associated with IH-induced decline in 
diaphragmatic activity, depending on which sex is being evaluated. Interestingly, these 
effects also seem to change in response to SCI (illustrated in Figures 5.1 and 5.2). In the 
presence or absence of injury, LTF is induced through a mechanism of increased 5-HT 
signaling, which strengthens synaptic connections on PMNs by stimulating BDNF 
synthesis to activate downstream phosphorylation and trafficking of glutamate 
receptors.224,268,288 Presence of 5-HT around putative PMN and synthesis of BDNF were 
not dependent on APOE genotype. However, levels of synaptic NMDA receptors were 
decreased in the presence of E4, suggesting a deficit in the signaling pathway 
downstream of BDNF synthesis that prevents NMDA receptor trafficking. This 
deficiency perhaps lies in BDNF activation of the TrkB receptor or in TrkB’s kinase 
activity, although more in-depth mechanistic studies are needed to determine how the 
human isoforms of apoE interact with this signaling cascade. Primarily, our data 
emphasizes the importance of understanding how factors that contribute to diversity in 
the human population, but are often incompletely represented by preclinical animal 




This is especially crucial in the context of therapeutic IH, which has undergone clinical 
trials to evaluate its efficacy in enhancing breathing recovery, as well as for a variety of 
other functional outcomes after SCI.41,140,142,403,404 By recognizing how factors such as sex 
and genetic background impact the response to therapeutics, we can begin to develop 
personalized approaches to overcome innate barriers to plasticity, regeneration, and 
neuroprotection, thereby facilitating translation of therapeutics and improving functional 
outcomes for people living with an SCI.  
5.2 Methodological Considerations and Limitations  
To accurately interpret our results, we must consider the limitations and potential 
pitfalls of our experimental approaches. Fortunately, a vast body of literature describing 
protocols of IH and other approaches to induce LTF, as well as the signaling required for 
its manifestation in spinally intact or injured rats, is available to provide context for our 
data. However, the same is not true regarding respiratory plasticity in mice. While this 
presented challenges for both experimental design and data analysis, it also enhances the 
value of the current studies for the field of SCI and neural plasticity. Examining the 
respiratory response to IH in both sexes of a humanized mouse model will pave the way 
for the use of more translationally relevant preclinical models. Due to the availability of 
transgenic mice that express a variety of human genes, they are powerful tools for 
exemplifying the diversity found in the human SCI population. 
 
5.2.1 Induction of LTF in Rats Treated with Human ApoE Protein 
Although LTF has been well-characterized as an augmentation of breathing 




exhibit the expected increases in ventilation.139,224,268,382 In the absence of injury, 
diaphragmatic activity remained constant in response to episodic 5-HT. Following C2 
hemisection, E3-treated animals did exhibit a slight increase in diaphragmatic activity, 
but this change did not reach significance. Although we followed the 5-HT dosing 
protocol that MacFarlane and Mitchell (2009) showed to be effective in rats, some 
aspects of our experimental preparation differed from those previously described. 
Notably, many studies record phrenic neurograms instead of diaphragmatic 
EMGs.247,268,382 This technique requires a phrenicotomy at least unilaterally, which 
removes phrenic afferent feedback and alters PMN excitability.514,515 Indeed, rats that 
undergo phrenicotomy prior to IH display enhanced LTF compared to those with intact 
phrenic nerves.514 Therefore the presence of intact phrenic nerves in our animals may 
have prevented more dramatic alterations in activity.  
Many LTF preparations also include bilateral vagotomy and artificial ventilation 
of animals in order to gain control of blood gases without interference from lung stretch 
receptor feedback.247,268,516 Because our apoE-treated rats were freely breathing, both 
phrenic and vagal feedback could have masked IH-induced breathing changes. An 
additional consequence of performing diaphragmatic EMG recordings in freely breathing 
animals without pCO2 monitoring is that we could not control for changes in metabolic 
rate. Small mammals such as rats and mice can respond to hypoxic exposures by 
activating hypoxic hypometabolism, a decrease in metabolic rate which decreases O2 
consumption to negate the need for increased ventilation when exposed to low 
environmental O2.
441 Due to confounding factors that may have decreased our sensitivity 




breathing response to IH in injured E3 and E4 rats. Although the observed trend did not 
reach statistical significance, we did observe significant E4-dependent changes in 
synaptic NMDA receptor levels, indicating that human apoE4 may prevent neural 
plasticity and synaptic strengthening in the injured spinal cord.384,385 
Inherent in our dosing protocol is some uncertainty regarding the diffusion pattern 
of intrathecal 5-HT and apoE, as well as what cell types these molecules interacted with. 
This 5-HT dosing protocol has been shown to induce LTF of phrenic nerve activity 
without altering activity of the hypoglossal nerve, suggesting that 5-HT reaches PMN in 
the cervical ventral horn but does not communicate with brainstem respiratory nuclei.382 
Therefore, human apoE proteins, which were applied to the spinal cord in the same 
manner presumably followed a similar diffusion pattern. However, we did not assess the 
distribution of apoE in the spinal cord or brainstem. ApoE, especially in its lipidated form 
binds receptors in the LDLR family, which are expressed by a variety of cell types 
(neurons, microglia, astrocytes, and oligodendrocytes), to activate an assortment of 
downstream signaling pathways.517–520 Intrathecal administration of apoE could have led 
to inconsistent distribution of the protein between cell types, as well as differences 
between animals, increasing variability in our data. To address this uncertainty and to 
ensure that human apoE isoforms were present at physiologically relevant levels in the 
spinal cord throughout developmental stages and recovery after SCI, subsequent studies 





5.2.2 Insights into a Novel Approach for Studying Respiratory Motor Plasticity in Mice 
 The literature describing the respiratory response to IH in mice is sparse. 
Consequently, there is a lack of knowledge regarding best practices for induction and 
measurement of LTF on this model. Although a few studies have shown that mice do 
express LTF, the methods of induction, as well as the type of LTF evaluated (e.g. 
hypoglossal, ventilatory, etc.) are inconsistent. None of them utilized spinally injured 
animals.231–233 Therefore, the optimal IH protocol for injured animals was determined 
based on previous studies in rats and mice, as well as our own observations in mice. 
Previous studies have shown that spontaneous recovery of diaphragmatic activity occurs 
by 2 weeks after lateral C2 hemisection in 40% of mice.287 All but two animals in this 
study recovered EMG activity by three weeks post injury (94% had spontaneous 
recovery), indicating that the mice had viable synaptic inputs on phrenic motor neurons 
that could undergo synaptic strengthening in response to IH. In rats, which recover 
diaphragmatic activity much more slowly after hemisection when compared to mice 
(Warren et al. 2018, personal observation), the crossed phrenic pathway (CPP) is not 
capable of mediating IH-induced LTF for over 2 weeks post injury due to lack of 5-HT in 
the phrenic motor nucleus. However, Michel-Flutot et al. (2021) recently shown that the 
mouse CPP is effective in response to respiratory challenge such as mild transient 
asphyxia as early as seven days post injury521. Based on data from previous studies, three 
weeks post injury was determined to be the time point when mice would be capable of 
inducing LTF through synaptic strengthening of CPP inputs on phrenic motor neurons, 
although further studies are needed to determine how expression of mouse LTF may be 




 In addition to the timing of therapeutic IH after injury, we also needed to 
determine the optimal IH protocol for inducing LTF. While much is known about impact 
of hypoxia severity and length on spinal plasticity in rats, this has not been well-
described in mice.230 Considering previous IH protocols that have been effective in mice, 
we chose a protocol similar to that used in freely breathing mice by Terada et al. (2008). 
The protocol in the current study applied three 5-minute hypoxic (11% O2) bouts 
separated by normoxic periods of 5-minute duration. This was sufficient to induce 
increases in breathing when preliminarily tested in wild type mice (data not shown). This 
protocol also replicates the “modest” IH exposures commonly applied to rats in order to 
activate the Q pathway to LTF without increasing blood pressure, systemic inflammation, 
and oxidative stress, which can result from more “severe” IH.224,268,522,523 The Q pathway 
is initiated through IH-induced release of 5-HT from spinal projections of the raphe.465 
This stimulates 5-HT2 receptor signaling on PMNs and results in synthesis of new BDNF 
that signals through the TrkB receptor.226,268,288,524 In contrast, more severe or sustained 
exposure to IH induces LTF through a 5-HT7 or adenosine 2a receptor-dependent 
signaling cascade that activates PKA to stimulate synthesis and transactivation of 
TrkB.477,525,526 
 Both the Q and S pathway are thought to activate phosphorylation and trafficking 
of glutamate receptors downstream of TrkB activation, thereby strengthening synaptic 
connections on PMN.226 However, simultaneous activation of Q and S cascades leads to 
crosstalk inhibition, preventing augmentation of breathing activity.229,479,480 Because LTF 
signaling mechanisms have not been so thoroughly scrutinized in mice, it is unknown 




Therefore, we are uncertain whether the IH protocol utilized in our study activated the Q 
pathway, S pathway, or both. Further studies examining how different IH strategies alter 
signaling in mouse PMNs will allow for optimization of IH protocols in mice, thereby 
ensuring that results are not confounded by crosstalk inhibition. 
 Another factor to be considered in the interpretation of our data and in future 
studies is the influence of circadian rhythms on breathing control and plasticity. Humans 
and rodents exhibit oscillations in body temperature, metabolism, and ventilation 
throughout a 24-hour period.527 Diaphragmatic EMG recordings in our rats and mice 
were performed at varying times throughout the day and therefore animals were not 
consistently in the same part of the circadian cycle. In addition to potential impacts on 
baseline respiratory activity in these animals, the circadian clock also regulates various 
types of neuroplasticity, including respiratory motor plasticity in the form of LTF.528–530 
Activity of the serotonergic raphe exhibits rhythmicity with the sleep/wake cycle and 
PMNs themselves express circadian clock genes.530,531 Expression of 5-HT2 receptors, 
BDNF, and TrkB also changes throughout the day, suggesting that animals exposed to IH 
or episodic 5-HT at different times may have varied in their propensity for plasticity.530 
Although disregarding time of day as a biological variable may have dampened the 
treatment effect in our animals, it simultaneously increases clinical relevance because 
studies investigating the neuroplastic response to IH in spinally injured individuals have 
also not performed IH at the same time of day in every subject.41,142,381,403,404 
 Similar to influences of circadian rhythms, hormone cycles could also impact the 
propensity for plasticity in our animals. The estrous cycles of the female rats and mice in 




time of treatment or diaphragmatic EMG recording. Progesterone and estrogen receptors 
are present in the CNS, including in the region of raphe serotonergic neurons. Here, 
signaling of these hormones increases expression of tryptophan hydroxylase, the rate-
limiting enzyme of 5-HT synthesis.532 Estrogen has also been shown to enhance levels of 
5-HT2 receptors and progesterone functions as a breathing stimulant that has been used to 
treat respiratory disorders.374,533,534 Interestingly, LTF in males requires conversion of 
testosterone to estradiol and female LTF is more pronounced during stages of the estrus 
cycle when 5-HT levels are high, emphasizing the importance of sex steroid hormones in 
5-HT-depended spinal plasticity.372,373,535 Indeed, Dougherty et al. (2017) found that 
induction of LTF is enhanced when circulating estradiol levels are highest. After 
ovariectomy-induced abolishment of LTF, administration of exogenous estradiol is 
sufficient to restore respiratory motor plasticity.536 Because we did not control for estrous 
cycle phase in our female animals, differences in hormone and 5-HT levels may have 
increases inter-animal variability and limited our ability to detect apoE isoform-
dependent effects. 
 Measuring the respiratory response to episodic 5-HT dosing and IH without 
controlling for time of day and levels of sex hormones may contribute to variability in 
our data and limit the interpretation thereof. However, this paradigm more accurately 
reflects the condition of human subjects receiving therapeutic IH in clinical investigations 
where conditions cannot be so tightly controlled. A limitation for the translational 
applicability of the current studies is that homogenous animal populations and preclinical 
injury models are not representative of human SCI. While the lateral C2 hemisection is a 




accurately model the diversity of SCIs seen in people. Human injuries are more closely 
replicated by contusive injury models. While less reproducible, contusion injuries 
realistically injure a variety of spinal fibers, including those of the CPP, which are likely 
to be damaged in individuals who have experienced a cervical SCI. Unfortunately, this 
means that C2 contusive injury models, unlike C2 hemisections, can lead to complete 
loss of breathing function in animals, presenting ethical and logistical concerns. To most 
accurately examine the potential for plasticity and recovery of function after cervical SCI, 
previous work has shown the viability of contusing the cord caudal to our hemisection 
injury at the C3/C4 level to preserve independent ventilation.210,537,538 Performing a 
similar contusive injury in APOE mice would strengthen the clinical relevance of our 
studies, an effort that is crucial to improving translation of therapeutic approaches for 
SCI. Indeed, a recent review by Fouad et al. (2020) emphasizes the importance of 
incorporating factors which cannot be controlled in the human population (sex, age, 
genetics, injury pathology, etc,) into preclinical studies to increase the validity of animal 
models, despite the risk of contributing to data variability.377 
5.3 Future Directions 
While the above data provides evidence that both APOE genotype and sex 
influence spinally mediated plasticity in rodent models of LTF, our results have also 
generated many more questions regarding the mechanisms behind these changes. Of 
particular interest is our description of how humanized mice respond to IH, which differs 
from the ventilatory response in rats. Future studies will contribute to our understanding 
of the role of apoE isoforms in modulating the function and plasticity of neural circuitry, 




our findings, future investigations will examine ways to address apoE isoform-dependent 
deficiencies in recovery of function and the response to SCI therapeutics. This will 
enhance the potential for translation of therapeutic approaches that will better serve the 
spinal cord injured population.  
 
5.3.1 ApoE-astrocyte interactions in spinal and respiratory plasticity.  
Astrocytes are the primary producers of apoE in the central nervous system.303 
ApoE that is synthesized and lipidated by astrocytes is internalized by neurons upon 
receptor binding, thereby providing cholesterol for growth and synaptogenesis.308 While 
this uptake of apoE is crucial for the modulation of neuronal activity, apoE also impacts 
the functioning of astrocytes themselves. During development, these cells play an 
important role in synapse remodeling. Each astrocyte can ensheath thousands of synapses 
and is sensitive to synaptic activity. In response to prolonged inactivity of excitatory or 
inhibitory synapses, astrocytes can phagocytose and degrade synaptic material to refine 
developing neural circuitry.323,539 Interestingly, during the first step of this process, the 
function of phagocytic receptors are modulated by ABCA1, the transporter responsible 
for astrocytic lipidation of apoE.540 The three isoforms of apoE uniquely interact with 
ABCA1, leading to different lipidation profiles of brain apoE.395,397 In addition to 
transporting lipids extracellularly, ABCA1 also translocates lipids within the membrane, 
suggesting that the apoE isoforms may alter how ABCA1 controls local membrane 
phospholipid composition and phagocytic receptor localization.540 During development, 
this could lead to APOE allele-dependent differences in synaptic connectivity in the 




increased 5-HT+ fiber staining in the phrenic motor nucleus of 4 mice in the current 
study (Chapter 3&4).324 Future studies investigating synaptic pruning mediated by in 
spinal cord astrocytes from APOE targeted replacement mice would provide further 
insights into the development of breathing circuitry and PMN synaptic connectivity in 
intact, genetically distinct spinal cords. 
Following SCI, phagocytosis is crucial to remove debris created by injury-
induced Wallerian degeneration, apoptosis, and demyelination. In the presence of apoE4, 
reduced phagocytosis could allow lingering breakdown products to activate persistent 
immune responses, aggravating secondary injury cascades and potentially leading to 
auto-immunity in the CNS.541,542 Investigating phagocytic processes in spinal astrocytes 
could reveal whether the APOE alleles alter the ability to remove inflammatory mediators 
from the injury milieu in order to prevent tissue damage. Genotype-dependent differences 
in this process could perhaps contribute to the neuroanatomical-functional paradox of 
SCI described by Fouad et al. (2020). 
In addition to phagocytic processes, the apoE isoforms also modulate astrocytic 
metabolism. Astrocytes are not only important for exporting lipids for apoE-mediated 
transport, they are also the primary CNS cell type performing -oxidation of fatty 
acids.543 Indeed, cortical astrocytes contain higher levels of tricarboxylic acid (TCA) 
cycle enzymes than neurons, contributing significantly to the 20% of energy produced in 
the brain that is produced by fatty acid oxidation.501,544,545 The fatty acid octanoate easily 
crosses the blood brain barrier and is responsible for much of the brain’s anaplerotic flux, 
contributes to gluconeogenesis for glucose oxidation, and itself undergoes fatty acid 




octanoate as precursors to ATP synthesis in the CNS, APOE genotype-dependent effects 
on lipid homeostasis have been of interest in the Alzheimer’s Disease literature. Human 
subjects expressing the 4 allele perform -oxidation at a higher rate than those who lack 
4.546,547 This hyperactivity and increased ATP synthesis is associated with cognitive 
impairment, an effect aggravated by age.548,549 However, some studies also indicate that 
the apoE4 protein leads to mitochondrial dysfunction and reduced ATP synthesis.506,550 In 
addition to its influence on lipid metabolism, apoE4 has also been associated with 
impaired glucose uptake and hypometabolism.502,551 Despite contradictory conclusions 
about the impact of apoE isoforms on ATP production, these studies demonstrate that 
apoE modulates flux through metabolic pathways in neurons and astrocytes. 
Measuring bioenergetics of astrocytes found in the phrenic motor nucleus or 
brainstem respiratory nuclei before and after SCI could reveal how apoE isoforms 
influence metabolism to change breathing function. SCI induces to a significant loss of 
mitochondrial function, leading to free radical production and exacerbating secondary 
damage, which may be further intensified depending upon apoE isoform-dependent 
impacts on mitochondria in the cervical spinal cord.11 Mitochondria could therefore be a 
powerful therapeutic target for alleviating isoform-dependent deficits in metabolism to 
enhance respiratory plasticity and the recovery of motor function after SCI.552,553 
Astrocytes contribute to the neural control of breathing in both the intact and 
injured state. In the rhythmic pre-Bötzinger complex (preBötC), astrocytes contribute to 
central chemosensation. Ablation of brainstem astrocytes attenuates the HVR, similar to 
the effect of inhibiting peripheral chemosensation of the carotid body, emphasizing the 




stimulates the release of vesicular ATP.554–556 Rhythmogenic preBötC neurons are 
excited by ATP and respond to purinergic signaling by increasing inspiratory frequency, 
thereby augmenting breathing activity upon astrocytic detection of low pH.557,558  
At the level of the phrenic motor nucleus in the cervical spinal cord, astroglial 
cells interdigitate with PMN, preventing direct communication between the motor neuron 
dendrites.559 Within hours after a C2 hemisection, these astrocytic processes actively 
retract, allowing the number of dendrodendritic appositions to increase, which is 
accompanied by the formation of additional excitatory bulbospinal synaptic connections 
on PMNs.560,561 This is thought to be a mechanism of plasticity contributing to activation 
of the latent crossed phrenic pathway after cervical SCI. APOE genotype-dependent 
influences on astrocytic metabolism or Ca2+ homeostasis may impact their ability to 
undergo structural reorganization that prompts strengthening of PMN connectivity. ApoE 
isoforms could also alter their capacity for sensing and transmitting information about 
brainstem CO2 levels through ATP release, potentially attenuating the respiratory 
response to hypoxia. Future studies investigating the impacts of apoE on astrocytes’ 
chemosensation function and capacity for remodeling in the breathing circuitry would 
contribute to our understanding of how genetic diversity in the human population may 
influence individuals’ capacity for respiratory plasticity in response to injury and 
ventilatory challenge.  
 
5.3.2 The inflammatory milieu after SCI: impact of APOE genotype   
As discussed in Chapter 1.1.1, the inflammatory response to SCI is a dynamic 




and neural plasticity. Interestingly, compared to apoE3 animals, humanized E4 mice 
express higher levels of pro-inflammatory cytokines after CNS insult, which is associated 
with a decline in synaptic markers.562–565 Clinically, the importance of understanding how 
apoE isoforms modulate CNS inflammatory responses is underscored by data showing 
that anti-inflammatory drugs can reduce risk of Alzheimer’s, but only in individuals 
expressing apoE4. This suggests that some detrimental effects of the E4 isoform may be 
alleviated by targeting neuroinflammation.566  
In addition to APOE genotype-dependent influences, inflammatory profiles after 
neurotrauma are also modulated by factors such as age and sex. Genotype-dependent 
effects in our data diverged according to sex, indicating that it will be important to 
investigate the mechanism behind the observed sex differences. As previously discussed, 
LTF itself is modulated by levels of sex hormones, especially estrogens, which are 
required for LTF even in males.371–373,434 Following neurotrauma, the acute inflammatory 
response to CNS injury also differs between males and females, with males exhibiting 
greater microglial activation and peripheral myeloid cell infiltration.567,568 The divergent 
response of immune cells is attributed to the immunosuppressive properties of estrogens. 
These female sex hormones attenuate the release of pro-inflammatory cytokines, 
upregulate anti-inflammatory cytokines, and enhance the T-cell response to clear myelin 
debris and improve functional outcomes in females.569,570 In contrast to estrogens, 
testosterone is associated with excitotoxicity and oxidative stress after SCI.571,572 Sex 
hormones also impact mitochondrial function, as demonstrated by the role of estrogens in 
maintaining metabolic homeostasis.573 Breakdown of metabolic processes after SCI 




advantage provided by female sex hormones.11,574 Conclusions from these previous 
studies indicate that APOE genotype and sex may interact to modulate the inflammatory 
response to SCI, leading to differences in respiratory plasticity and functional recovery.  
To determine how sex and APOE alters respiratory and spinal plasticity through 
modulating inflammation, future studies will utilize a more recently characterized model 
of plasticity that relies on the presence of inflammatory mediators. This form of 
respiratory motor plasticity is known as inactivity-induced motor facilitation (iPMF) and 
leads to augmentation of breathing activity similar to that observed during LTF.238 
However, it differs from LTF in both its means of induction and the signaling pathways 
that lead to its manifestation. While LTF develops in response to heightened inspiratory 
drive elicited by exposure to hypoxia, iPMF results from a lack of respiratory drive. High 
levels of mechanical ventilation removes the drive to breath, leading to a neural apnea. 
When inspiratory drive is restored and phrenic nerve activity returns, compensatory 
plasticity becomes evident in the form of enhanced phrenic activity.238 This facilitation is 
dependent upon signaling of the TNF- cytokine, implicating the involvement of 
inflammatory responses to apnea.237 Therefore, evaluating lesion characteristics and 
iPMF in male and female mice expressing human APOE alleles will provide insight into 
how sex and APOE genotype impact both immune activation and plasticity after SCI.  
Astrocytes may also be key mediators in the induction of iPMF. Astrocytes are 
known to respond to synaptic inactivity by releasing TNF-. This signaling stimulates 
synaptic localization of glutamate receptors in neurons, thereby strengthening synaptic 
connections.241 Although this mechanism is typically associated with gradual changes in 




the development of iPMF34. Utilizing iPMF as a model of plasticity in intact and spinally 
injured animals will allow for the investigation of how astrocytic activation and 
signaling, glutamate receptor trafficking, and respiratory plasticity are impacted by APOE 
genotype.  
 
5.3.3 Considering age as a biological variable in studies of the apoE isoforms.  
APOE rose to notoriety in the Alzheimer’s Disease field as the most significant 
genetic risk factor for developing this disease. However, Alzheimer’s is a disease of 
aging, and accordingly, age is the primary determinant of Alzheimer’s risk. Aging further 
exacerbates apoE4- and sex-dependent effects on brain pathology and cognitive decline. 
Indeed, previous data indicates that apoE4 may enhance synaptic plasticity in some brain 
regions in young humanized APOE mice, but this effect disappears with age.447,448 
Females are at greater risk of developing Alzheimer’s, as well as more pronounced E4-
dependent tau pathology and deficits in neural circuitry connectivity even before disease 
onset.575,576 In aged mice expressing 4, estradiol replacement therapy enhances LTP, 
improves memory, and reduces Alzheimer’s risk, indicating that female sex hormones are 
neuroprotective against detrimental effects of apoE4 in the CNS.577,578  
Together, evidence from the Alzheimer’s Disease literature underlines the 
importance of considering both age and sex as biological variables when investigating the 
influence of apoE isoforms on neural plasticity and CNS disease outcomes. This is 
especially relevant for the current work because spinal cord injuries are becoming 
increasingly common in older individuals. SCIs used to be a young person’s injury, with 




population ages, the average age has increased, with falls emerging as a more prevalent 
cause of injury in the older population. Although the average age of injury is currently 
43, SCIs have a bimodal distribution, proving to be most common in young adults and 
elderly individuals.2,579 In our study, APOE humanized mice were 3 months old 
(representative of young adults) when they received an SCI. Future experiments using 
aged animals would be valuable in determining whether age exaggerates genotype and 
sex effects on spinal and respiratory plasticity in a manner agreeing with trends described 
in the neurodegeneration literature.  
SCI in older individuals elicits pathological responses that are distinct from those 
found in young adults, activating secondary injury cascades that could determine the 
extent of tissue damage, injury severity, and the response to therapeutic interventions.580–
583 Clinically, it is difficult to isolate age-dependent influences on outcomes after SCI due 
to a variety of covariates including age-related comorbidities, lack of precise outcome 
measures, and variability in injury characteristics.584 For example, lengths of stay in 
rehabilitation facilities are reduced in the older SCI population because older individuals 
are more likely to sustain incomplete lesions. Despite the higher prevalence of complete 
injuries, younger people still recover independent walking after SCI more frequently than 
elderly individuals.585 Due to the challenging nature of clinical SCI aging studies, it is 
important to develop preclinical models that will accurately reflect the human condition, 
including representation of genetic diversity, sex, and age. By utilizing humanized mouse 
models, future studies will provide a means of studying how APOE genotype-dependent 




Previous studies have shown that mitochondrial function declines with age, 
leading to increased production of reactive oxygen species.586 Some types of age-
dependent mitochondrial dysfunction are more pronounced in the spinal cord than in the 
brain, suggesting that if apoE isoforms inhibit spinal plasticity through altering 
mitochondrial bioenergetics, these detrimental effects will be exacerbated by aging.587  
Accordingly, the E4 isoform is associated with heightened oxidative damage in the 
Alzheimer’s brain, although E4’s impact on spinal cord ROS production remains 
unexplored.588 However, in wild type animals, increased mitochondrial ROS production 
after SCI activates spinal cord macrophages, which more commonly develop a pro-
inflammatory phenotype in aged animals.580,581 Strikingly, even M2 macrophages, which 
are typically considered protective in young animals, produce more ROS while 
concurrently releasing fewer anti-inflammatory cytokines after SCI in older 
animals.580,582 Reducing macrophage activation and ROS production enhances 
neuroprotection and improves functional recovery after SCI in aged mice, presenting a 
promising therapeutic target if apoE isoform-dependent effects on oxidative stress and 
immune activation are discovered.583  
 
5.3.4 Therapeutic interventions for overcoming apoE-induced constraints on breathing 
plasticity 
The emergence of APOE genotype-dependent impacts on respiratory and spinal 
plasticity in our data raises a critical question: how do we ameliorate functional deficits 
that result from an individual’s genetic make-up? While sex differences also contributed 




through hormone replacement. In the brain, estradiol replacement has shown efficacy in 
enhancing plasticity to improve learning and memory in women who express the 4 
allele.577,578 Estradiol may similarly restore spinal plasticity in 4 females, while also 
acting as a neuroprotective antioxidant after SCI.589 Because previous data has also 
indicated that excess hormone replacement can exacerbate brain aging in females who 
lack the 4 allele, the effects of estradiol on CNS function and plasticity in the presence 
of human APOE alleles must be further investigated to assess its potential risks and 
benefits.590 Estrogen signaling is also important for plasticity in the male CNS, which is 
emphasized by data showing that estradiol is required for LTF in male rats.372 Indeed, 
estradiol treatment can improve functional outcomes in male rats that sustain a traumatic 
brain or spinal cord injury, emphasizing the importance of testing its therapeutic potential 
in both sexes of humanized APOE mice.370,591,592  
Although modulating the levels of sex hormones may alleviate some of the 
observed impacts of APOE genotype on the propensity for plasticity in our animals, a 
more effective approach may be to directly target apoE proteins. To overcome barriers to 
plasticity that arise from the unique structures and molecular interactions of each apoE 
isoform in the brain, apoE mimetic peptides and structure correctors have been 
developed. The amino acid substitutions at positions 112 and 158 lead to different 
intramolecular interactions in apoE isoforms, altering their ability to interact with other 
molecules.593 Protein levels of apoE in the CNS are also APOE allele-dependent, with 
lower levels observed in individuals expressing 4.594 This suggests that interactions 
between apoE and its receptors are altered in E4 animals due to both its structure and 




binding domain of apoE, which is common between the E2, E3, and E4 proteins. This 
allows the peptides to interact with apoE receptors and mediate the neuroprotective and 
anti-inflammatory actions of apoE3.595–597 Indeed, mimetic peptides have shown 
preclinical efficacy in reducing CNS inflammation and improving functional outcomes 
after SCI and TBI, in addition to protecting against Alzheimer’s pathology.598,599 
Mimetic peptides increase apoE receptor activation by increasing levels of the 
receptor binding domain that can effectively bind apoE receptors. In contrast, small 
molecule structure correctors interact with the apoE4 protein itself in order to interrupt 
intramolecular domain interactions that result from the Cys112Arg substitution. This 
causes E4 to acquire a more open tertiary structure that resembles E2 or E3.600–602  
Structure correctors prevent apoE4-induced impairment of neurite outgrowth and 
mitochondrial dysfunction.601,603 Although this therapeutic strategy has not been tested in 
the context of SCI, future exploration of the possibility of converting apoE4 into the 
functional equivalent of apoE3 could reveal enhanced respiratory plasticity in spinally 
injured E4 females. 
While directly targeting the structure or molecular interactions of apoE isoforms 
may alleviate their detrimental impacts on CNS function and plasticity, they could also 
have unintended side effects in the periphery, where apoE is also highly expressed.317 
Therefore, it may be more translationally relevant to target signaling pathways that are 
altered by apoE isoforms in the brainstem and spinal cord where the neural circuitry that 
mediates breathing is housed. One crucial signaling molecule that is modulated 
differentially by the apoE isoforms in the CNS is calcium.604 Specifically, apoE4 disrupts 




intracellular calcium levels is associated with increased neuronal cell death.328 SCI also 
stimulates Ca2+ influx, further exacerbating the disruption of Ca2+ homeostasis caused by 
apoE4, which could explain why detrimental effects of E4 were only observed after 
injury in our rat model.605  
Mitochondria function as cellular Ca2+ regulators. Excessive Ca2+ can interrupt 
mitochondrial bioenergetics and lead to opening of the mitochondrial permeability 
transition pore, allowing for the release of reactive oxygen species and apoptotic 
proteins.553,606 As previously discussed, oxidative damage stimulates inflammatory 
processes and vice versa, demonstrating that loss of Ca2+ homeostasis has significant 
implications for metabolism and secondary injury after SCI.  
High calcium levels could also inhibit synaptic plasticity through activation of 
calcineurin, a Ca2+-dependent phosphatase607. While some entry of Ca2+ through calcium-
permeable AMPA receptors can be lead to beneficial enhancement of synaptic 
transmission, excessive Ca2+ signaling can have the opposite effect.608 Increased Ca2+ 
influx in mice expressing 4 is associated with heightened activity of calcineurin, which 
reduces the density of dendritic spines and inhibits synaptic plasticity, possibly through 
dephosphorylation of glutamate receptors.329,609 Together, previous studies describing the 
interactions of apoE isoforms, Ca2+ signaling, cytotoxity, and synaptic plasticity suggest 
that restoring calcium homeostasis may alleviate E4-associated deficits in respiratory 
plasticity before or after SCI. The therapeutic efficacy of approaches that prevent 
mitochondrial permeability transition or which reduce calcineurin activity, such as 
cyclosporine A or FK-506, respectively, should also be investigated for their ability to 




5.4 Conclusion  
Together, our data shows that both sex and human APOE genotype determine the 
propensity for spinal and respiratory plasticity. When considered in the context of the 
neurotrauma and Alzheimer’s Disease literature, this general conclusion is not surprising, 
although the specific genotype-dependent responses did not follow the patterns that have 
previously been described in the brain. The 4 allele has previously been associated with 
attenuated synaptic plasticity and worse functional outcomes in traumatic brain injury 
and Alzheimer’s, effects which are more pronounced in females. However, the current 
study demonstrated that both the 3 and 4 alleles can inhibit spinal and respiratory 
plasticity, depending on sex and the injury status of the spinal cord. This is the first 
investigation of how genetic diversity in the human population may alter the propensity 
for spinal and respiratory plasticity, as well as the ability to respond to SCI therapeutics. 
Our novel findings underscore the importance of considering biological variables in the 
human SCI population when developing therapeutic approaches. While preclinical animal 
models can never comprehensively represent the extent of diversity found in people, 
utilizing multiple species, transgenic animals, both sexes, and clinically relevant injury 
models can provide better predictors of the efficacy of treatment strategies in diverse 
patient populations. Understanding how factors such as APOE genotype impact the 
response to therapeutics that are entering clinical trials, including IH, will aid in the 
development of personalized strategies to overcome barriers to functional recovery. 
Fundamentally, our data will pave the way for improving translation of SCI therapeutics 






Figure 5.1 Graphic summarizing sex- and genotype-dependent differences in 
the respiratory response to IH  
Injured (left) and C2 hemisected (right) APOE targeted replacement mice displayed 
unique responses to IH, which were dependent upon sex and APOE genotype. (Created 





Figure 5.2 Graphic illustrating the signaling pathway that leads to 
manifestation of LTF. 
Numbers indicate the molecules that were quantified in APOE targeted replacement mice 
or apoE-treated rats. The panel on the bottom right summarizes whether there were apoE 
isoform-dependent differences in the levels of these molecules: 1-2) Injured APOE mice 
displayed genotype-dependent differences in the amount of 5-HT density of the PNN 




apoE-treated rats or APOE mice. 4) ApoE4 was associated with a decline in synaptic 





Appendix 1. List of Abbreviations: 
 
ABCA1 = ATP binding cassette A1 
AD = Autonomic dysreflexia 
AIS = American Spinal Injury Association Impairment Scale 
AMPA = -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ANOVA = Analysis of variance 
ApoE = Apolipoprotein E 
ATP = Adenosine triphosphate 
BDNF = Brain derived neurotrophic factor 
CNS = Central nervous system 
CPP = Crossed phrenic pathway 
CSPG = Chondroitin sulfate proteoglycan 
DP = Diaphragm pacing 
ELISA = Enzyme-linked immunosorbent assay 
GDNF = Glial cell-derived neurotrophic factor 
HIV = Human immunodeficiency virus 
HVR = Hypoxic ventilatory response 
LDLR = Low density lipoprotein receptor 
LTF = Long term facilitation 
LTP = Long term potentiation 
MP = Methylprednisolone 
MRI = Magnetic resonance imaging 
NADPH = Nicotinamide adenine dinucleotide phosphate 
NIH = National Institutes of Health 
NLI = Neurological level of injury 
NMDA = N-methyl-D-aspartic acid 
NMDA = NMDA receptor 
NSAID = Nonsteroidal anti-inflammatory drug 
NTS = Nucleus tractus solitarius 
OCT = Optimal cutting temperature 
PBS = Phosphate buffered saline 
PFA = Paraformaldehyde 
PMN = Phrenic motor neuron 
PNN = Perineuronal net 
RMANOVA = Repeated measures ANOVA  
ROI = Region of interest 
SCI = Spinal cord injury 
TBI = Traumatic brain injury 
TMS = Transcranial magnetic stimulation 
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